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ABSTRACT
TOBACCO - GENE ACTIVITY PROFILES IN PORPHYROMONAS GINGIVALIS,
FILIFACTOR ALOCIS AND TREPONEMA DENTICOLA

Neelima Chowdary Cherukumalli, BDS
April 18, 2016

Smoking is an established risk factor for periodontitis. Prior studies have shown
that cigarette smoke extract (CSE) can induce profound phenotypic changes in
Porphyromonas gingivalis and alters the virulence of this important periodontal
pathogen. We hypothesized that CSE might also alter gene expression in
established periodontal pathogens, Porphyromonas gingivalis and Treponema
denticola, as well as in the emerging pathogen, Filifactor alocis. Oral bacteria were
grown in CSE-conditioned medium (1000 ng/ml nicotine equivalents) or in
unconditioned control medium. Total RNA was extracted and CSE-regulated
genes were identified by comparison of the mRNA profiles of CSE with control
cultures using RNA-Seq analysis. Approximately, 30% of genes in the P. gingivalis
genome and 5% of genes in the F. alocis genome were found to be differentially
expressed when exposed to cigarette smoke. Several genes responsible for DNA
replication and repair, transfer (tra) genes, ABC transporter genes and several
metabolic genes were found to be differentially expressed in both F. alocis and P.
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gingivalis. Validation of RNA-Seq differentially expressed genes was done by
qPCR analysis for selected genes and similar results were found. More in depth
study of these genes could provide some of the first insights into how cigarette
smoke changes the P. gingivalis and F. alocis phenotype in a manner likely to
promote their colonization and infection.
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CHAPTER 1: INTRODUCTION

Tobacco and Disease
Tobacco is the single biggest preventable reason for death and illness in
the United States. According to the World Health Organization, there were around
1.3 billion smokers worldwide in 2003, and that number is relied upon to increment
to 1.7 billion by 2020 (1). Cigarette smoking kills more than 480,000 Americans
each year, with more than 41,000 of these deaths from exposure to secondhand
smoke (2). In addition, smoking-related illness in the United States costs more than
$300 billion a year (2, 3).
Cigarette smoke is a complex mixture of chemical compounds.
Researchers have estimated that cigarette smoke has > 7000 chemical
compounds from many different classes (4). Components of smoke are contained
in either the particulate phase or the gas phase. The particulate phase ingredients
include tar, polynuclear hydrocarbon phenol, cresol, catechol and trace elements
which are carcinogens; indol, carbazole (tumor accelerators) and 4-aminobiphenyl
(known to cause hepatocellular carcinoma) (5). The gas phase contains carbon
monoxide, hydrocyanic acid, acetaldehyde, acrolein, ammonia, formaldehyde and
oxides of nitrogen, nitrosamines, hydrazine, and vinyl chloride that have
carcinogenic activity (6,7,8,9). Nicotine in cigarette smoke is highly addictive. In
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little doses nicotine goes about as a stimulant to the brain. In substantial doses,
it's a depressant, repressing the signals between nerve cells. In considerably
bigger doses, it's a deadly toxic substance, influencing the heart, veins, and
hormones (10).
There is a positive association between tobacco smoking and cancers of
the lung, oral cavity, pharynx, larynx, esophagus, pancreas, bladder, kidney,
pelvis, nasal cavities, paranasal sinuses, nasopharynx, liver, stomach, kidney and
cervix (12). Smoking accounts for at least 30% of all cancer deaths and 87% of
lung cancer deaths. In the United states, tobacco use is responsible for nearly 1 in
5 deaths (11). In 2012, the estimated percentage of new lung cancers in males
and females was 14% each. Among these lung cancers, 29% of male and 26% of
female cases were estimated to be fatal (11).
Smoking and Infectious diseases
Smokers are more susceptible to multitude of infectious diseases compared
to non-smokers (13). These include respiratory tract infections, pneumonia,
tuberculosis, meningitis, sexually transmitted bacterial infections and bacterial
induced periodontal diseases (14-20). The specific mechanisms by which cigarette
smoking increases the risk of systemic infections are incompletely understood.
They are multifactorial and can be due to Mechanical and Structural or
Immunologic changes caused by smoking (21). Cigarette smoke and many of its
components like acrolein, acetaldehyde, formaldehyde, free radicals and nitric
oxide, are believed to be responsible for structural alterations in the airway
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epithelial cells, which is thought to predispose to the development of upper and
lower respiratory tract infections (22,23).
Cigarette smoking alters various cellular and humoral immune system
functions. These alterations include a (i) decreased level of circulating
immunoglobulins. Several studies have found that smokers had serum
immunoglobulin levels (IgA, IgG, and IgM) 10% to 20% lower than those of
nonsmokers (24-27), (ii) depression of antibody responses to certain antigens,
such as influenza virus infection (28) and Aspergillus fumigatus infection (29), (iii)
decrease in CD4+ lymphocyte counts, an increase in CD8+ lymphocyte counts.
Since

CD4+

cells

facilitate

B-cell

proliferation

and

differentiation

and

immunoglobulin synthesis, decrease in the CD4 count seen in heavy smokers (≥
50 pack-year) might contribute to the increased susceptibility to infections in this
population. Increase in CD8+ cells in heavy smokers (≥50 pack-year) has also
been found to be associated with infection (30,31,32), (iv) depressed phagocyte
activity. There is reduced migration and chemotaxis of Polymorphonuclear
leukocytes in the peripheral blood of smokers compared with PMNs from
nonsmokers (33,34). Also motility and chemotaxis of PMNs are depressed in the
oral cavity of smokers compared with nonsmokers (33), and (v) decreased release
of proinflammatory cytokines. The release of cytokines from macrophages may
also be altered in smokers. Studies showed that there is decrease in IL-1, IL-6 and
TNF (35,36).
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Figure 1: Diseases related to smoking
Image showing association between smoking and various cancers and chronic
diseases. The conditions in red are the new diseases that have been linked to
smoking in the 2014 report by surgeon general and conditions in black are linked
to smoking by USDHHS in 2004, 2006 and 2012.
Photo courtesy of: U.S. Department of Health and Human Services (USDHHS). The Health Consequences of Smoking—
50 Years of Progress: A Report of the Surgeon General. Atlanta (GA): U.S. Department of Health and Human Services,
Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office
on Smoking and Health, 2014.

Smoking and chronic inflammatory diseases
Tobacco smoking is known to substantially increase the risk for chronic,
inflammatory diseases (14,15,37,38), such as acute vascular diseases (40,41),
inflammatory bowel disorders (42,43) renal disease (15), pancreatitis (16) and
periodontal diseases (44). Smoking is a major cause of cardiovascular diseases
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and the risk for these diseases increases with the quantity of cigarettes smoked
per day and the duration of smoking history (2). Chemicals in cigarette smoke can
increase vascular permeability and activate adhesion molecule expression,
resulting in increased leukocyte adhesion and, eventually, platelet aggregation.
This can narrow the blood vessels and lead to cardiovascular conditions like
atherosclerosis, acute myocardial infarction and stroke (45,46). Also, smoking
increases blood pressure and decreases tolerance to exercise (46).
Smoking increases risk for lung diseases like chronic bronchitis (47,48), a
long-term inflammation of the bronchi (large airways). The chemicals in cigarette
smoke irritate and activate macrophages and epithelial cells. This causes the cells
to release multiple types of cytokines which lead to thickening and inflammation of
the airway lining. This persistent inflammation caused by cigarette smoke can
change the structure of the airways and make them narrower through a cycle of
injury and repair (49). Smoking is also associated with other chronic inflammatory
renal diseases like inflammatory bowel disease and chronic kidney disease
(50,51).
Periodontal diseases
Periodontal diseases are one of the most predominant diseases all through
the world (52). They represent a group of infectious inflammatory diseases
affecting the supporting and surrounding tissues of teeth (53). They are second to
dental caries as a cause of tooth loss among adults in developed countries (54),
affecting 47.2% adults aged 30 years and older in the US (55). Periodontal
diseases happen as a consequence of mixed microbial infections within which
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specific groups of bacteria coexist. In a healthy mouth there are more than 350
species of microorganisms and periodontal infections are linked to less than 5% of
these organisms (56). Porphyromonas gingivalis, Treponema denticola, Prevotella
intermedia, Aggregatibacter actinomycetemcomitans, Tannerella forsythia, and
Fusobacterium nucleatum are believed to play prominent roles in the etiology of
periodontal diseases (56). Recent studies have identified a wide range of bacteria
associated with disease status like Filifactor alocis, Selenomonas, Synergistes,
Desulfobulbus and TM7 (57,58). These bacteria exist as an organized biofilm on
the tooth surface. Extension of the biofilm into the gingival sulcus begins a series
of events that mediate periodontal disease (59).
In the gingival sulcus, pathogenic bacteria and their metabolic products
initiate the inflammatory response in host cells (neutrophils, epithelial cells and
macrophages). This results in an influx of an inflammatory infiltrate which is rich in
neutrophils. These neutrophils attempt to phagocytose the bacteria (60). However,
some periodontal pathogens have developed ways to resist phagocytosis using
virulence factors like capsules, or avoid phagocytosis by gaining entry into host
cells (61). Another method of fighting periodontal pathogens is neutrophil
degranulation. When neutrophils degranulate, they release granular enzymes
such as elastase, and matrix metalloproteinases (MMPs) as well as superoxide
and oxygen radicals, and nitric oxides. These products do not discriminate
between the bacteria and the host tissues. Thus, periodontal tissue destruction will
result from prolonged exposure (62).
Smoking and periodontal diseases
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Compared to non-smokers, tobacco smokers are more susceptible to
plaque-induced gingivitis and periodontitis. There is a negative, dose-dependent
relationship between smoking and periodontal health (63,64). Smokers are also
more refractory to periodontal treatment than non-smokers (64).
Smoking has been shown to affect various aspects of the host immune
response. It has adverse effects on fibroblast function (65), chemotaxis and
phagocytosis by neutrophils (66), and immunoglobulin production (67).
Macrophages play important roles in both cell mediated and humoral immunity as
antigen-presenting cells. However, antigens are presented in the context of class
1 major histocompatibility complex (MHC) surface molecules. There might be a
gradual reduction in the humoral immune response in smokers because of reduced
expression of class I MHC by the alveolar macrophages in smokers (68,69).
Smokers show increased gingival recession and alveolar bone loss, greater
periodontal ligament (PDL) attachment loss and deeper gingival pocket formation
that is responsible for increased tooth mobility and tooth loss at an earlier age than
non-smokers (70,71). Smoking has also been shown to reduce the concentration
of serum IgG (25, 72,73). Smoking is also known to alter the host inflammatory
response to plaque bacteria. According to several studies, nicotine activates the
anti-inflammatory pathway and suppresses pro-inflammatory cytokine production
(74-78). Also there is reduced levels of pro-inflammatory cytokines, such as IL-1
(84,85,86) in the gingival crevicular fluid (GCF) of smokers with periodontitis
compared to non-smokers with periodontitis, whereas anti-inflammatory cytokines
like IL-10 and TGF-β1 are increased in the GCF of smokers (79,80,81).
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Despite being more susceptible to periodontitis and exhibiting faster
disease progression and severity, chronic smokers lack the clinically overt
inflammatory response to bacterial plaque that non-smokers exhibit such as
redness, swelling, bleeding on probing making diagnosis of the disease more
complicated in smokers (45,82).
Porphyromonas gingivalis
Porphyromonas gingivalis is a Gram-negative, proteolytic, asaccharolytic
anaerobe. Although this bacterium is a natural member of the oral microbiome, it
can proliferate to high numbers in periodontal lesions and can be highly destructive
(83,84,85). P. gingivalis is found in significantly higher numbers in smokers
compared to non-smokers and the infection is more persistent (70,86).
The “red complex” bacteria Porphyromonas gingivalis, Treponema
denticola, and Tannerella forsythia, are frequently isolated together and are
strongly associated with advanced periodontal lesions (56,87-89), but according
to recent studies periodontal diseases are caused by synergistic and dysbiotic
microbial community rather than “select periopathogens” such as “red complex”
(88). So the concept of “red complex” has been superseded by the “Keystone
pathogen” hypothesis, at least in mice. This indicates that certain low-abundance
microbial pathogens can cause inflammatory disease by increasing the quantity of
the normal microbiota and by changing its composition (88). For instance,
Porphyromonas gingivalis has been shown to manipulate the native immune
system of the host (90). By doing so, it was hypothesized that it not only facilitates
its own survival and multiplication, but also that of the entire microbial community.
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Intensive study has revealed multiple virulence factors which are responsible for
the survival and pathogenesis of P. gingivalis.
Major fimbrial antigen (FimA)
The major fimbriae of P. gingivalis are long, hair-like, peritrichous, adhesive,
filamentous structures that project away from the cell surface (91). They are
primarily comprised of a 41 kD protein (FimA, fimbrillin) encoded by the fimA gene
(92). P. gingivalis fimbriae adhere to a wide variety of molecules and oral
substrates, which include salivary molecules, such as proline-rich proteins, prolinerich glycoproteins, statherins, oral epithelial cells, fibrinogen, fibronectin,
lactoferrin, and bacteria, such as oral streptococci and Actinomyces species (9396). Long fimbriae interact with glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) allowing for localization of P. gingivalis on the streptococcal surface (97).
Human GAPDH has also been shown to bind to long fimbriae (98).
Based on its nucleotide sequence variation, the fimA gene has been
classified into six types (I, Ib, II, III, IV, V) (99,100). fimA genotypes II, Ib, and IV
were shown to cause inflammatory changes in animal models (101,102,103).
Recombinant protein of fimA genotype II is known to adhere to and invade human
epithelial cells than fimA from other genotypes (104). In human Gingival epithelial
cells (GECs) long fimbriae are also known to induce cytokines involved in bone
resorption, such as tumor necrosis factor (TNF), interleukin-1b (IL-1b), IL-8, and
IL-6 by stimulating nuclear factor-kB (NF-kB) via TLR 2 and CD14 (105, 106, 107).
Minor fimbrial antigen (Mfa1)
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Short fimbriae (Mfa1 fimbriae) are homopolymers of a subunit protein
encoded by the mfa1 gene, with a molecular mass of 75 kDa (92,108). They are
shorter than the major fimbriae and can be easily seen when the latter are absent
(101). Short fimbriae mediate co-adhesion between P. gingivalis and S. gordonii
via adhesin-receptor interactions with streptococcal SspA and SspB surface
proteins (109). Studies have reported that short fimbriae induced the expressions
of cytokines, including IL-1α, IL-1β, IL-6, and TNF, in both human monocytic cell
lines and mouse macrophages by interacting with TLR2 and CD14 (110,111).
Capsule
The P. gingivalis capsule is composed of glycosamionglycans and plays an
important role in providing resistance to stressful conditions (112). It can help
shield the microbe from the host defense and modulate host physiology (113) by
providing resistance against neutrophils (114) and complement-mediated lysis or
opsonization (115). The higher virulence potential of encapsulated strains
compared to that of non-encapsulated ones, evaluated using a mouse abscess
model, suggests that the capsule plays a significant role in the pathogenesis of this
bacterium (116,117).
P. gingivalis capsule allows bacteria to escape host immune defenses by
inhibiting the host immune response, thus promoting bacterial survival and growth
(118). Recent studies show that encapsulated P. gingivalis strains trigger different
host responses than non-encapsulated mutant strains (119,120). P. gingivalis K1
serotype capsular polysaccharide is capable of eliciting chemokine production
from macrophages that in turn promote cell migration (121). Defensins, a small
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antimicrobial peptides produced by host cells have a bactericidal effect. P.
gingivalis capsule reduces the bactericidal effect of these peptides contributing to
increased survival of the organism (122). The non-encapsulated PgC strain is less
virulent than the encapsulated W50 strain, demonstrating that capsule plays a role
in the virulence of P. gingivalis in the mouse abscess model (111). However, the
role of capsule in the virulence of P. gingivalis is still vague.
Lipopolysaccharides (LPS)
The outer leaflet on the outer membrane of Gram-negative bacteria is
comprised of lipopolysaccharide (123), which is atleast 10 kDa in size (84)
Components of lipopolysaccharide are O-antigen, core, and lipid A. Lipid A is
responsible for endotoxic activity, while the O-antigen is responsible for significant
immunobiological activity (124) and is the easiest target for the humoral response
of the host. The O antigen is recognized by the innate immune response and
participates in complement activation (125,126). Many studies have established
the immunobiological importance of the lipopolysaccharide of Gram negative cell
wall envelope (127,128). It has the ability to activate the host inflammatory
responses and disrupt bone remodeling process (129,130). P. gingivalis LPS binds
to the CD14 and TLR-4, activating macrophages, epithelial cells respectively,
leading to secretion of pro-infammatory cytokines (131,132).
P. gingivalis is known to show an unusual amount of lipid A heterogenicity
containing both tetra-acylated and penta-acylated structures (134). Compared to
E. coli, P. gingivalis Lipid A is heterogenic with varying numbers and positions of
phosphate and fatty acid groups (134). When human monocytes were stimulated
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with P. gingivalis LPS, the level of TNF, IL-1β and IL-6 was enhanced (133). LPS
in P. gingivalis also plays a critical role in inducing cells to secrete pro-inflammatory
cytokines, which mediate inflammation and participate in periodontal connective
tissue destruction and alveolar bone resorption. P. gingivalis LPS is significantly
less inflammatory than other Gram negative bacterial LPS such as that of E. coli.
This might be because of differences in lipid A structure, reduced 4′
phosphorylation, reduced acylation at the 3 and 3′ positions on the back bone and
the absence of acyloxyacyl group at the 3′ position (135).
Proteases including gingipains
The classification of the proteases has relied upon their catalytic
mechanisms. There are four categories of P. gingivalis proteases: serine, cysteine
and metalloproteinase. These include gingipains (Arg- or Lys-), periodontain
(cysteine endopeptidase), PrtT proteinase, Tpr proteinase, collagenase (prtC
gene), prolyl tripeptidyl peptidase (serine exopeptidase), dipeptidyl-peptidase IV
(serine exopeptidase known as glycylprolyl peptidase, a product of the dppIV
gene), dipeptidyl-peptidase VI (putative cysteine exopeptidase), amino-peptidase
P, oligo-peptidase O and gelatinase (a proteinase degrading type IV collagen,
gelatin, low-molecular-mass-kininogen and transferrin) (136). Of these, the
collagenases, aminopeptidases, and the trypsin-like proteases are critical to P.
gingivalis pathogenesis (137).
Gingipains are cysteine proteases that can cleave the proteins at arginine
and lysine specific sites (138). All the extracellular and cell-associated protease
activity with specificity for arginine peptide bonds is derived from two genes, rgpA
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and rgpB. All the extra- cellular activity with specificity for lysine peptide bonds is
derived from a single gene, kgp (139). These are important etiological agents in
periodontal diseases.
P. gingivalis proteases degradae and metabolise the extracellular matrix
proteins (137). Gingipains have collagenolytic activity and degrade or inactivate
inflammatory cytokines IL-6, IL-8, TNF and IFN. Proteases (Trp, PrtT) have MMPactivating or hemagglutinating properties. Dipeptidyl amino- peptidase IV (DPPIV)
may also act as a virulence factor by contributing to the degradation of connective
tissue (140,141).
Filifactor alocis
F. alocis is a Gram-positive, slow-growing, asaccharolytic, obligate
anaerobic rod (142). It was first isolated in 1985 in the gingival sulcus of gingivitis
and periodontitis patients and was classified as Fusobacterium alocis (143). Later,
based on phylogenetic analysis of 16s rRNA, it was reclassified into the genus
Filifactor

(144).

The

size

of

the

F.

alocis

genome

is

1.93

Mb

(www.broadinstitute.org). Cultivable strains of F. alocis include, ATCC 35896, D62D (clinical strain) (145) and CCUG 47790 T (www.straininfo.net). F. alocis is
present in diseased periodontal pockets in higher numbers than in healthy mouths
(146,147). Arginine, which increases the growth of F. alocis in vitro, is abundantly
present in periodontal pockets (148). This has been hypothesized to help explain
the presence of F. alocis in high numbers in periodontal pockets (149).
The gingival crevice is lined by epithelial cells, the first cells to be
encountered by periodontal bacteria (150). Epithelial cells produce of the
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chemoattractant cytokines like IL-8 which are responsible for signaling of the
underlying tissues (151). Neutrophil migration into the gingival crevice is thought
to be the first line of defense against plaque bacteria (152,153). F. alocis adheres
to and invades the surface of gingival epithelial cells (GECs) (143). The secretion
of proinflammatory cytokines IL-1, IL-6 and TNF by GECs are increased when
infected with F. alocis (154). Such cytokines can induce osteoclastic activity and,
thus, increased bone resorption (155). The effect of F. alocis on cell viability was
investigated by observing the levels of apoptotic and necrotic cells after infection
and it was confirmed that F. alocis stimulates apoptosis in GECs through the
extrinsic apoptotic pathway, as it increases caspase-3 production (154). Transient
activation of MEK1/2 and long term inhibition of MEK activity is caused by F. alocis.
MEK1/2 activates MAPK pathways which can control cell proliferation and
differentiation (154). Inhibition of MEK leads to induction of apoptosis in various
cell types (156). Thus the pro-apoptotic effect of F. alocis is a result of its ability to
inhibit MEK activity. All these effects of F. alocis on gingival cells may be
responsible for the tissue destruction caused in periodontitis.
Virulence factors of F. alocis
Oxidative stress resistance
Periodontitis is characterized by the generation of reactive oxygen species
(ROS) (166) by activated phagocytes at the gingival sulcus (157,158). ROS have
the ability to initiate the destruction of connective tissue, and increasing ROS levels
may kill different pathogens. So, oxidative stress resistance is important for the
survival of an organism in the periodontal pocket (149). In broth culture, the
14

generation time was approximately 13 hours for F. alocis 35896 and 3 hours for P.
gingivalis. When grown with 0.25mM of hydrogen peroxide to test their adaptation
to oxidative stress (142), the generation time of F. alocis was 6 to 7 hours
compared to 10 hours for P. gingivalis, which shows that F. alocis is more resistant
to oxidative stress conditions than P. gingivalis. Also the growth of F.alocis
appeared to be stimulated under such conditions (142). This might be another
reason that helps explain the ability of F. alocis to thrive in the periodontal pocket
(146). The exact mechanism underlying the oxidative stress resistance of F. alocis
is not known. F. alocis has sialidase activity (142) which is important for the survival
and pathogenesis of periodontal pathogens (160). This sialidase activity results in
release of sialic acids that act as an ROS scavenger to reduce oxidative stress in
the periodontal pocket (152). F. alocis has a putative neutrophil activating protein
A (NapA). H. pylori NapA co-localizes with DNA, causing it to accumulate in one
area of the bacterial cell protecting its DNA from damage by free radicals (161).
There is a speculation that this neutrophil activating protein A may be an important
virulence factor in F. alocis. It may also be responsible for the survival and
stimulated growth of the bacteria under oxidative stress conditions (142) using a
mechanism similar to that of H. pylori. Therefore, it is likely that the ability of F.
alocis to survive oxidative stress in the periodontal pocket contributes to its ability
to establish itself in this niche.
Proteases
Proteases are important virulent factors of several oral pathogens (163). In
Streptococcus mutans (164), Porphyromonas gingivalis (165) and Fusobacterium

15

nucleatum (166), proteome analysis has been used to understand the molecular
mechanisms of bacterial invasion, survival and pathogenesis. When similar
proteome analysis was performed in F. alocis ATCC 35896 and D-62D, strainspecific variation in their protein profiles was observed and a few proteases that
could potentially play an important role in the pathogenesis were identified (167).
The F. alocis genome has a putative total of 15 different proteases. Both strains of
F. alocis have CaaX proteases (167) which are known in S. gordonii for their role
in protein transportation and protection from bacteriocins produced by other similar
bacteria (168). Protease HMPREF0389_00122 is present in the extracellular
fraction of the D-62D strain and is known to have a collagen peptidase function.
This protease might be responsible for the damage of the connective tissue which
leads to tissue destruction in periodontitis (167). So this could be important in F.
alocis pathogenesis. Proteins that play a crucial role in the amino acid metabolism
are seen in F. alocis (142). Although F. alocis lacks some inherent amino acid
synthesis pathways, the release of required amino acids through protein
degradation with the help of these proteases and peptidases may be important for
F. alocis survival. F. alocis has proteins responsible for ornithine catabolism and
urea breakdown (167) and this well-developed nitrogen assimilatory pathway may
also be involved in alternative amino acid synthesis pathways (169). So we can
conclude that F. alocis has mechanisms to provide for its nutritional needs. One of
the major virulence mechanisms in bacteria is their ability for extracellular secretion
of proteins (170). Proteins involved in type-II secretory pathway, namely, Type IV
pilus

assembly

protein

(HMPREF0389_00426)
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and

trigger

factor

(HMPREF0389_01646), were also identified in the membrane fraction of the F.
alocis ATCC 35896 (167). F. alocis D62-D proteins, leucotoxin translocation ATPbinding protein, fibronectin-binding protein, type IV pilus assembly protein, fimbrial
assembly protein, hemolysin III type calcium-binding protein, toxin-antitoxin
component protein and Na +/H + antiporter protein (NAPA) homologous to K+/H ÷
antiporter (171), are considered virulence factors in other microorganisms (167).
F. alocis also has glycolytic enzymes, such as phospho-glycerate mutase and
glyceraldehyde 3-phosphate dehydrogenase, that are responsible for energy
metabolism (167). These virulence proteins and glycolytic proteins might have
protein moonlighting functions such as mediating binding of bacteria to proteins of
the extracellular matrix (ECM) like fibronectin (172), which is important for bacterial
virulence in several human pathogens. Moonlighting proteins are multifunctional
proteins which perform multiple autonomous, often unrelated, functions (173).
These proteins add another dimension to cellular complexity and benefit cells in
several ways (174). In conclusion, all of these proteins seen in F. alocis may
contribute to its virulence but the exact role of these systems in the bacterial
community is not clearly known.
Treponema denticola

Treponema denticola is a helically shaped Gram-negative Spirochete that
is motile and flexible. It has periplasmic flagella, which allow for mobility by using
a proton motive force to cause thrusting through rotation (175).
Oral treponemes are a part of the polymicrobial biofilm (176). They play an
important role in the etiology of several chronic diseases like chronic periodontitis,
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acute necrotizing ulcerative gingivitis and dental abscesses (177-180).
Treponemes are present normal healthy individuals in low numbers (181).
T. denticola has an ability to bind with Fusobacterium (182,183), early
colonizing Streptococcus crista (184), P. gingivalis and T. forsythia (185,186,187).
When co-cultured, P. gingivalis and T. denticola form significantly increased biofilm
formation compared with monoculture (185). These interactions may be important
for T. denticola to colonize and persist during health.
Virulence factors of T. denticola
Little is known about the virulence factors of T. denticola but they are
believed to have features needed for adherence, invasion and damage of the
periodontal tissues.
Leucine-rich repeat proteins (Lrr)
A T. denticola leucine-rich repeat protein (LrrA) has recently been shown to
play a role in binding to T. forsythia. Also leucine-rich repeat protein in T. forsythia
has been shown to be important for epithelial cell invasion and virulence in a
mouse alveolar bone loss model (186-190) and is believed to have similar function
in T. denticola.
Dentilisin
Dentilisin is proposed to be a major virulence factor of T. denticola. It
contributes to disease progression by disrupting or modulating intercellular host
signaling pathways and degrading host cell matrix proteins (191). It also allows for
penetration of epithelial cell layers by T. denticola through degradation of
intercellular adhesion proteins (191) and modulates host cell immune responses
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through degradation of interleukin-1β (IL-1β), IL-6, tumor necrosis factor alpha
(TNF), and monocyte chemo attractant protein 1 (192,193).
Major sheath protein (Msp)
Msp is an abundant protein in the T. denticola outer membrane. It has
surface-exposed loops that are able to bind to a variety of host proteins (181). Msp
has been proposed to mediate colonization of host tissues (194,195). It is also one
of the immunodominant T. denticola antigens recognized by human serum
antibodies (196). Msp interaction leads to actin remodeling and reorganization in
host cells, which is likely how it impairs neutrophil chemotaxis and phagocytic
activity (197-200).
Lipoproteins
Lipoproteins are the most abundant membrane-associated proteins found
in spirochetes, and T. denticola 35405 is predicted to have 166 of them, the highest
number for any of the sequenced spirochetes (201). The role of these in T.
denticola virulence is as yet unresolved, but they are likely to be responsible for
epithelial cell binding and invasion, subversion of the complement cascade, or
tissue invasion (202,203).
Outer Membrane Vesicles (OMVs)
Initially, OMV were thought to be the result of random blebbing of the outer
membrane, or sheath, producing small spherical vesicles of 50-100 nm in
diameter. However, recent studies have revealed that OMVs are formed by a
highly regulated process which may increase the fitness of the bacterium in
response to environmental stress (204,205,206). OMVs are considered potent
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virulence factors, since they possess adhesins, toxins, and proteolytic enzymes
that can mediate bacterial aggregation and invasion and can modulate the host
immune response (205). T. denticola outer sheath vesicles (OSVs) can penetrate
tissues more readily than the bacterium itself (207,208,209). Application of T.
denticola OSVs to Hep-2 epithelial cell monolayers disrupted the tight junctions,
which could facilitate penetration into underlying tissues (210). However, the
involvement of treponemal OSVs in disease remains to be properly explored.
Smoking and Periodontal Pathogens
Tobacco-induced susceptibility to periodontitis was also believed to be associated
with shifts in the microbial composition from one that is mainly constituted of Gram
positive, aerobic, commensal bacteria to one that contains more Gram negative,
anaerobic pathogens (211-218). Haffajee and Socransky (219) showed an
increased prevalence of eight species, including P. gingivalis, in current smokers,
while Eggert et al. (216) have shown a higher prevalence and proportion of T.
forsythia, C. rectus, P. gingivalis and P. micros in plaque samples from smokers.
A recent study done by Camello Castello et al.et al... (221), showed that there is
an increased presence of Filifactor, Tanerella, Schwartzia, Bullleida and
Anaeroglobus in chronic periodontitis patients who smoke compared to nonsmoking chronic periodontitis patients and non-smoking healthy individuals. Also
molecular studies have demonstrated that smokers with periodontitis have a
diverse sub gingival microbial profile compared to non-smokers with periodontitis
(198,200,201), which was contradicted in a recent study which showed that
smokers with periodontitis has decreased bacterial diversity (221).
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According to Bagaitkar et al. (222), several functionally-related genes
including multiple genes in the major fimbrial and capsular polysaccharide
operons, as well as genes encoding transcriptional regulators; efflux pump and
transport proteins; proteases and cell envelope proteins, were dysregulated when
P. gingivalis W83 was exposed to cigarette smoke extract conditioned media using
Microarray analysis (222). Also she found that cell surface or outer membrane
proteins, i.e., RagA, RagB and PG0179 were shown by biochemical approaches
to be present at higher levels after CSE treatment. But the genes encoding for
these components were not identified as differentially expressed in her microarray
experiments (222). This reflects inherent limitations in the microarray approach.
However, till today, very little is known about how tobacco smoke affects the
phenotype of periodontal pathogens.
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HYPOTHESIS
Cigarette smoke extract (CSE) represents an environmental stressor to which
bacteria may adapt by several different mechanisms, one of which is by altering
their gene expression. So, we hypothesize that established periodontal pathogens
P. gingivalis, T. denticola and emerging periodontal pathogen F. alocis adapt to
this environmental stress caused by cigarette smoke extract by altering their gene
expression.
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CHAPTER 2: MATERIALS AND METHODS

Bacterial Culture and in Vitro Modelling of Tobacco Exposure
Porphyromonas gingivalis ATCC 33277, Filifactor alocis ATCC 35896 and
Treponema denticola ATCC 35405 were purchased from the American Type
Culture Collection (Manassas, VA) and maintained as frozen stocks. Growth
medium for P. gingivalis - Gifu anaerobic medium (GAM), was purchased from
Nissui Pharmaceutical (Tokyo, Japan). Growth medium for F. alocis - Brain heart
infusion (BHI), was purchased from Becton, Dickinson and Company (Sparks, MD)
and infused with L-cysteine (0.1%) and arginine (20%) purchased from SigmaAldrich (St. Louis, MO). Growth medium for T. denticola - Tryptone-yeast extractgelatin-volatile fatty acids-heat inactivated rabbit serum (TYGVS) (223). 3R4F
standard reference cigarettes were obtained from the Kentucky Tobacco Research
and Development Center (Lexington, KY).

All three media (GAM, BHI and

TYGVS) were conditioned with cigarette smoke extract by drawing cigarette smoke
through 50ml of the medium by using a three-way stopcock and a syringe, with
35ml drags performed every 20 seconds. This cigarette smoke extract conditioned
medium was then filtered (0.2mm). Nicotine content was determined by gas-liquid
chromatography and adjusted to 7.2 pH and 1000 ng/ml nicotine concentration.
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P. gingivalis, F. alocis, and T. denticola were grown in their respective
control and cigarette smoke extract conditioned media under anaerobic conditions
(80% N2, 10% H2, 10% CO2) at 370c. For all experiments, bacteria were grown
either in control or CSE conditioned media and bacterial cells were harvested at
mid to late log phase (P. gingivalis- O.D 600 nm =1.0, corresponding to 109 cells
per ml; F. alocis- O.D 600nm =0.35, corresponding to 3×109 cells per ml;
T. denticola- O.D 600 nm = 1.6, corresponding to 8×109 cells per ml).
Isolation of Total RNA
Total RNA was isolated from bacterial cells according to manufacturer’s
instructions using one of two kits. Perfect Pure TM RNA Cultured Cell Kit by 5 Prime
(Gaithersburg, MD) was used for P. gingivalis and T. denticola. RiboPure

TM

–

Bacteria by Ambion life sciences (Thermofisher, Waltham, MA) was used for the
Gram positive F. alocis. Gram positive bacteria require an additional step to break
the thick peptidoglycan layer. The quantity and quality of RNA was measured by
performing a Nanodrop on a ND-1000 Spectrophotometer and then samples of
RNA were stored at -800C.
RNA-seq Analysis
Total RNA samples of P. gingivalis, F. alocis and T. denticola were sent to
University of Michigan for RNA-Seq analysis. They first removed rRNA using a
Ribo-zero rRNA removal kit by Epicentre (Chicago, IL). TruSeq RNA (nonstranded) kit by Illumina (Madison, WI) was used to generate m-RNA focused
libraries. Once the libraries were generated, they were sequenced on 2 lanes using
50bp single end reads. These raw reads were then sent to University of Michigan
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Bioinformatics core, where quality of the reads was checked using FastQC
(version 0.10.1). Tuxedo Suite software was used for alignment, differential
expression analysis and post-analysis diagnostics. Bowtie2 (version 2.1.0) was
used to align reads to the respective reference genome. FastQC was used for a
second round of quality control (post-alignment), to ensure that only high quality
data would be input to expression quantitation and differential expression analysis.
Cufflinks/CuffDiff (version 2.1.1) was used for expression quantitation and
differential expression analysis and CummeRbund was used to generate
diagnostic plots. Genes having ≥1.5-fold change were classified as up regulated
genes and genes with ≤0.6-fold change were classified as down regulated genes.
Enrichment Analysis of RNA-Seq data
KEGG and DAVID enrichment analysis were done on the differentially expressed
P. gingivalis and F. alocis genes to identify significantly enriched functional
categories.
Validation of RNA-Seq data
Differentially expressed genes of interest were confirmed by quantitative PCR
analysis using an Applied Biosystems 7500 Real Time PCR system. Primers were
designed using the qPCR primer design software, Primer Quest, provided by
Integrated DNA technologies (http://www.idtdna.com/Primerquest/Home/Index).
Table 1: P. gingivalis oligonucleotide primers used for quantitative PCR
Gene ID

Forward primer 5'-3'

Reverse primer 5'-3'

PGN_1047

TTCCATAGCCAAACGTGTAGAG

CTGAGAGCCAACCGATCATATT

PGN_0295

GGGTTCACTCAGTGCTCAAA

GAGCCATCCAAACACTCGATAG

kgp

AGGACAGGGTGAAGTTGTAATC

GCCTGCTTCGAATGTGAAATC

PGN_1367

CTCCGGGTAAGGCTGTTAATG

CAGCCACTTGTCCACTTCTT

PGN_1740

TGAATGAGGGAGGAGAGGATAC

ATGGAGAATGGCTGCTTGAG

25

PGN_1644

GGCTGAAGATGGAAGAGGTATC

GATGGCGGGAAAGTTGTTTG

upp

AGATGCGCGATGTCACTATTC

GGGTCATCTTCTTGCTGATCTC

PGN_0134

TCCATCATCAACGCCAAGAG

GGCCGAAAGAAGTCCGTATT

PGN_0885

CACCCTATGCTTTGCCTCTT

CGAAGGCTCATGGGTGAATAA

PGN_0545

CCTCTTGCTTTGTACGACTATCT

AGACTGGATCACTGCTTCTATTC

RgpA

GGACCGACGAAAGAAGATGATTA

CTTCCACCACCTTCGCTTATAG

PGN_0727

CCCTTTATGCTTGCGGTATTG

AAGGAAGGCGGGTGATATTT

PGN_1695

TAGGAGCATTGGATCAGAGTGGTG

GAAAGCCGGAGAAGTAATCATCC

RpoC

CGAAGGTGTAGTGGAGAATGT

CATAGGGAGCCATCGTCTTATC

Dps

CGCTGAAGAATGTGACCGATA

TCAAATCCACCGTTACCTCATC

PGN_0173

GGATCAAGTCGGAGTGGAATAC

CTTTAGAGGGAGCCGACATAAC

PGN_0175

GCGTATCCTCTCTGAAGTTGTT

GGTATCCTCCGATGCGATATG

PGN_1080

GTAACTATGCAGCCGGTATGA

CGGCTTCGTCTATGTACTTCTT

PGN_0724

AACTTCTCGGATGCCTTCTTAC

CGCAAAGCCTCTTACCTCTT

PGN_0660

TGGCTTATCGTGGCTCTTTC

GGAGGATCTCTTCTGCATCAC

Table 2: F. alocis oligonucleotide primers used for quantitative PCR
Gene ID

Forward primer 5'-3'

Reverse primer 5'-3'

HMPREF0389_00184

CCATAGAGGCGGAGGACTTA

GCTCCTCACCATCAAGTACATAG

HMPREF0389_00178

GATGCCTGCTTGATGAGTTTG

GCTGAGATTGTGCCTGAAGTA

HMPREF0389_00166

CTGACACCGACCATCATCAA

GCGGTTCATAGTTCCCGATAA

HMPREF0389_00226

GAAGGACCTGTGGCTATGATTT

AGCCTTATTACCGAGTCCTACA

HMPREF0389_00802

GAACAGTGGAAGAGGCGATAAG

AAGCCACTCTCCTTCCCTAA

HMPREF0389_01353

ATGGAAGAAGAAGGCTGTAAGG

ACTCTCTATGCAACGGACAAG

HMPREF0389_00799

CTAAGGGTCTGTTGCTGAATCT

CTATGGCGAACCTCCTGTATTT

HMPREF0389_00800

CCGACTCAGATTGTAGTGGAAA

CAGCAAGCCATCTCCTTCTAA

HMPREF0389_00155

ACATCATAGACAGCAGATATAGGG

GTTGCCATTTCGAGAAGTCTG

HMPREF0389_00186

GGGCAAATGGACCGAATAAC

GCTTGGTGAAACGGGATTAC

HMPREF0389_01079

TTGTCACCTTGCCGTTTCT

CCAAGTGCCGCTCTGATATT

HMPREF0389_00246

GCACCCTTTGAAGCCTTTATC

CTCCTGTAGACTTTCACGATCC

HMPREF0389_00154

ACTATCCATTATCTACAATGCTCCT

TCTTGCCATATTCTTTCATCATCAG

HMPREF0389_00969

TCGTTTCGGGAGCATTGG

AAAGTTCTCCGCCTACCATAAC

HMPREF0389_00162

AAGCAGAAGAGTGGCGAAA

CCCATGTGAATTGTCGGTATTTG

HMPREF0389_01096

GTTCTGGAGATGGGTGTTTCT

CCCTCTGCCCTTATTACCATATT

HMPREF0389_00644

AGGTCGTGGCTATGTTGATG

GACTGTCTGCTGTTGGTTAGT

HMPREF0389_01592

ACAGCCTTAATCGGTTCGAG

CTCACTTATATCTTCTCCGCCTATC

HMPREF0389_00823

GGCACATATTTCCGGTAAACTTC

CTTTCTCCATGTGATACGACCT

HMPREF0389_00879

TCGCAAGTCACTCAGGAAAG

CTGTTCCGACACCTACCATAAT

Primers were designed for the species specific 16s rRNA gene, which was our
reference gene.
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P. gingivalis 16s rRNA - F: TGTAGATGACTGATGGTGAAAACC
R: ACGTCATCCCCACCTTCCTC
F. alocis 16s rRNA -

F: CAGGTGGTTTAACAAGTTAGTGG
R: CTAAGTTGTCCTTAGCTGTCTCG

Primers

were

ordered

from

Biosynthesis

(www.biosyn.com)

and

were

reconstituted and stored at -200C. Total RNA (up to 1 μg) was reverse transcribed
to cDNA using Superscript ® III- First Strand Synthesis Super Mix by Invitrogen
(Waltham, MA) following manufacturer’s instructions and stored at -200C. SYBYR
Green Master Mix for qPCR analysis was ordered from Quanta Biosciences
(Gaithersburg, MD) and the manufacturer’s instructions were followed to set up a
reaction. Reaction conditions used for qPCR were 500C for 2 minutes, 950C for 10
minutes, and 950C for 15 seconds – 45 repetitions and 600C for 1 minute. An
additional dissociation stage was added to check for validity of primers which
included 950C for 15 seconds, 600C for 1 minute, 950C for 15 seconds and 600C
for 15 seconds.
Statistical Analysis
All experiments were done in triplicate unless otherwise mentioned. Statistical
significance between groups was evaluated by one-way nonparametric ANOVA
and Fisher multiple comparison test. A probability value ˂ 0.001 was considered
statistically significant.
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CHAPTER 3: RESULTS
Growth of (P. gingivalis, F. alocis and T. denticola) in CSE- conditioned media
We compared the growth of bacteria in CSE-conditioned and non-conditioned
medium in order to determine if 1000 ng/ml nicotine equivalency was toxic to P.
gingivalis, T. denticola or F. alocis. Similar growth characteristics were observed
for all three species at this concentration of CSE. As shown in Figures 2, 3 and 4,
the bacteria can tolerate this dose of CSE. All further experiments were done at
1000 ng/ml nicotine equivalency, a dose that is relevant to the concentration of
nicotine found in the periodontal pockets of cigarette smokers (224).
GAM

GAM-CSE
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Figure 2: Effect of CSE on P. gingivalis growth
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Growth curve of P. gingivalis in unconditioned GAM and CSE conditioned GAM.
Triangles represent the growth of P. gingivalis in CSE conditioned media and
squares represent the growth in GAM. Error bars represent the mean Standard
deviation (SD) of 3 experiments. There were no statistically significant differences
in the growth curves between experimental conditions.
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Figure 3: Effect of CSE on F. alocis growth
Growth curve of F. alocis in unconditioned BHI and CSE conditioned BHI.
Triangles represent the growth of F. alocis in CSE conditioned media and squares
represent the growth in BHI. Error bars represent the mean Standard deviation
(SD) of 3 experiments. There were no statistically significant differences in the
growth curves between experimental conditions.
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T. denticola density (O.D 600 nm)
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Figure 4: Effect of CSE on T. denticola growth
Growth curve of T. denticola in unconditioned TYGVS and CSE conditioned
TYGVS. Triangles represent the growth of T. denticola in CSE conditioned media
and squares represent the growth in TYGVS. Error bars represent the mean
Standard deviation (SD) of 3 experiments. There were no statistically significant
differences in the growth curves between experimental conditions.
P. gingivalis differentially expressed genes
RNA-Seq analysis was performed in order to determine the differentially expressed
genes of P. gingivalis when exposed to CSE. A total of 644 were found to be
differentially expressed (P < 0.005). 54 genes were up regulated and 590 genes
were down regulated.

30

Up regulated genes (> 1.5 fold) include the arginine and lysine gingipain
encoding genes, kgp, rgpA and rgpB; genes encoding arginine and proline
metabolism (PGN_1367, PGN_ 0504 and PGN_1434); genes encoding DNA
binding (PGN_1740, dps and rpoC); a group of genes responsible for carbohydrate
and energy metabolism, these include nitrogen metabolism (PGN_1047 and
PGN_1367) and several genes encoding carbohydrate metabolism ( PGN_1695,
PGN_0173, PGN_1753, PGN_0504, PGN_1529 and PGN_1755).
Table 3: List of up regulated genes in P. gingivalis upon CSE exposure
Gene ID

Gene name

Gene ID

Gene name
methylmalonyl-CoA
decarboxylase beta
subunit
conserved
hypothetical protein
with predicted
lysozyme domain

Gene ID

Gene name

PGN_1172

acyl-CoA dehydrogenase

PGN_1000

glycine cleavage system
protein H

PGN_1962

hypothetical protein

PGN_0504

PGN_1047

hydroxylamine
reductase

PGN_1670

PGN_0295

C-terminal domain of
Arg- and Lys-gingipain
proteinase

PGN_0731

hypothetical protein

PGN_0099

peptidase

kgp

Lys-gingipain

PGN_0503

biotin carboxyl carrier
protein

PGN_0301

outer membrane protein

PGN_1367

glutamate
dehydrogenase

PGN_1048

hypothetical protein

PGN_1014

elongation factor G

PGN_1740

RNA polymerase ECFtype sigma factor

ustA

PGN_1752

ferredoxin 4Fe-4S

rgpA

RgpAc;
glycosyltransferase

PGN_1755

PGN_1174

electron transfer flavoprotein
alpha subunit

PGN_0727

4-hydroxybutyryl-CoA
dehydratase

PGN_1529

PGN_1419

hypothetical protein

PGN_1695
rpoC
dps
PGN_0173
PGN_1753
PGN_1080
PGN_0649
PGN_0660
PGN_0724

fructose-1,6bisphosphate aldolase
DNA-directed RNA
polymerase subunit
beta'
DNA-binding protein
from starved cells Dps
glyceraldehyde 3phosphate
dehydrogenase type I
2-ketoisovalerate
ferredoxin reductase
branched-chain amino
acid aminotransferase
hypothetical protein
alkyl hydroperoxide
reductase
NAD-dependent 4hydroxybutyrate
dehydrogenase

upregulated in
stationary phase
protein A
2-oxoglutarate
oxidoreductase
subunit beta
2-oxoglutarate
ferredoxin
oxidoreductase
subunit beta

Lys- and Rgp- gingipain
domain protein
2-oxoglutarate
oxidoreductase subunit
gamma

PGN_0033

thioredoxin

PGN_2065

rgpB

arginine-specific
cysteine proteinase
RgpB

PGN_1756

PGN_0496

cytochrome B subunit

PGN_1578

elongation factor Tu

PGN_1434

aminoacyl-histidine
dipeptidase

PGN_0498

succinate
dehydrogenase/fumarate
reductase iron-sulfur subunit

PGN_0805

hypothetical protein

PGN_0809

TonB protein

PGN_0806
PGN_1418

MotA/TolQ/ExbB
proton channel protein
pyruvate-flavodoxin
oxidoreductase

PGN_1120
PGN_1739

NADPH-NAD
transhydrogenase
hypothetical protein
(lipoprotein)

PGN_0604

ferritin

mfa1

Mfa1 fimbrilin

PGN_1880

malate
dehydrogenase

PGN_1655

electron transport complex
RsxE subunit
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PGN_1995

hypothetical protein

aspA

aspartate ammonialyase

PGN_1352

hypothetical protein

Table shows gene ID number and name of all P. gingivalis genes that were up
regulated (> 1.5 fold) when exposed to CSE conditioned media.
Down regulated genes (< 0.6 fold) include genes encoding proteins that
may be involved in DNA replication, recombination and repair (e.g., PGN_1216,
PGN_2011, and PGN_0644); the transfer gene cluster (traJ, traK, traM, traA and
traG); Several genes in the ABC transporter operons (e.g., PGN_1325,
PGN_1324, PGN_0706, PGN_0707 and PGN_0708); minor fimbrial operon
(mfa1); several operons of transposases and partial transposases; genes
encoding nucleotide excision, repair and metabolism (PGN_0327, PGN_1706,
PGN_0195); putative endonuclease gene (PGN_1801) and genes in the capsular
biosynthesis locus (PGN_110 and PGN_1072).
Table 4: List of down regulated genes in P. gingivalis upon CSE exposure
Gene ID

Gene name

Gene ID

Gene name

Gene ID

Gene name

Gene ID

Gene name

PGN_0196

xanthine/uracil
permease

PGN_1644

transposase in ISPg1

PGN_0210

transposase in ISPg1

PGN_0385

integrase/recombinas
e XerD

uvrC

excinuclease ABC
subunit C

PGN_0706

exported periplasmic
protein

PGN_0405

alpha-1,2mannosidase

PGN_0439

hypothetical protein

PGN_1526

hypothetical protein

PGN_0206

lipid A disaccharide
synthase

PGN_2013

cation efflux system
protein

PGN_1024

ribosome-binding
factor A

PGN_0549

dTDP-glucose 4,6dehydratase

PGN_1324

ABC transporter
membrane protein

PGN_0820

hypothetical protein

PGN_1627

4-amino-4-deoxy-Larabinose transferase

PGN_1713

PAP2 superfamily protein

PGN_0524

PAP2 superfamily protein

PGN_1669

transposase in ISPg1

PGN_0738

phosphoglycerate
mutase

upp

uracil
phosphoribosyltransferase

ispD

2-C-methyl-D-erythritol 4phosphate
cytidylyltransferase

traJ

conjugate transposon
protein TraJ

PGN_1491

hypothetical protein

PGN_0134

biotin synthetase

PGN_1901

transposase in ISPg1

PGN_0324

transposase in ISPg1

PGN_1586

hypothetical protein

PGN_1177

transposase in ISPg1

PGN_1132

transposase in ISPg1

PGN_0056

conjugate transposon
protein

PGN_0688

hypothetical protein

PGN_0885

nitroimidazole resistance
protein

PGN_1984

hypothetical protein

PGN_1794

hypothetical protein
(glycerate kinase)

PGN_1259

histidinolphosphate
aminotransferase

PGN_0216

hypothetical protein

PGN_1216

transposase in ISPg1

PGN_1337

hypothetical protein

PGN_t004
9

tRNA-Ala
tRNA-Ala

PGN_0545

sulfatase

PGN_0153

hypothetical protein

PGN_1957

transposase in ISPg1

PGN_t001
4

PGN_0260

hypothetical protein

PGN_0959

transcriptional
regulator

PGN_0113

hypothetical protein

PGN_0195

xanthine
phosphoribosyltransferas
e

PGN_0220

partial transposase in
ISPg1

PGN_1511

hemolysin

PGN_0971

transposase in ISPg1

PGN_1929

hypothetical protein

PGN_0148

hypothetical protein

PGN_0058

conjugate transposon
protein

PGN_1899

hypothetical protein
(TPR domain protein )

murQ

N-acetylmuramic
acid-6-phosphate
etherase

PGN_0966

partial transposase in
ISPg1

PGN_1886

NAD dependent
epimerase

PGN_1831

ribosome-associated
GTPase

PGN_1950

hypothetical protein
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PGN_1077

transposase in ISPg1

PGN_1455

hypothetical protein

PGN_1309

ferrous iron transport
protein B

PGN_0777

PGN_1456

hypothetical protein

PGN_0490

DNA-damage-inducible
protein F

PGN_0858

ABC transporter ATPbinding protein

PGN_0317

PGN_1706

phosphoribosylglycinamid
e formyltransferase

PGN_1241

hypothetical protein
(glycosyl transferase
family protein)

PGN_t002
8

tRNA-Arg

PGN_1276

PGN_0807

DNAse related protein

PGN_2009

hypothetical protein

PGN_1110

partial transposase in
ISPg1

trmE

PGN_0810

hypothetical protein

PGN_1568

hypothetical protein

PGN_0832

gliding motility protein
SprA

PGN_1724

PGN_2030

hypothetical protein
(membrane protein)

PGN_1645

dipeptidyl-peptidase III

PGN_1300

transcriptional
regulator

rnhB

PGN_1734

nucleoside permease
NupG

PGN_0406

glycosyl
transferase
decarboxylating
precorrin-6Y
C5,15methyltransferase
transposase in
ISPg1
tRNA modification
GTPase TrmE
glycosyl
transferase group 2
family protein
ribonuclease HII
alpha-1,2mannosidase
family protein
Hypothetical
protein (DNAbinding helix-turnhelix protein )
transposase in
ISPg1

PGN_1044

alpha-amylase

PGN_0967

partial transposase in
ISPg1

PGN_1302

hypothetical protein (Oantigen polymerase)

PGN_1050

M24 family peptidase

PGN_0145

hypothetical protein

PGN_0089

PGN_0797

hypothetical protein

PGN_1025

hypothetical protein

PGN_1668

glycosyl transferase
group 2 family protein

PGN_1161

PGN_1583

hypothetical protein

PGN_1383

hypothetical protein (DNA
alkylation repair protein)

PGN_0587

transposase in ISPg1

PGN_1213

ATP-binding
protein

traM

conjugate transposon
protein TraM

PGN_1365

hypothetical protein

PGN_t005
2

tRNA-Gly

PGN_0104

transposase in ISPg1

PGN_0379

hypothetical protein

PGN_1471

hypothetical protein

PGN_0240

ferrochelatase

PGN_1539

ABC transport system
exported protein

PGN_1798

UbiE/COQ5 family
methlytransferase

PGN_0372

hypothetical protein

PGN_0702

hypothetical protein

PGN_0700

traK

conjugal transfer protein
TraA

PGN_1822

hypothetical protein

PGN_t005
3

tRNA-Cys

PGN_0716

PGN_0242

glycosyl transferase family
1

PGN_1039

alpha-1,2-mannosidase

PGN_1636

hypothetical protein

PGN_1723

hypothetical protein

PGN_0602

transposase in ISPg1

PGN_1312

transcriptional regulator

PGN_1131

hydrolase

PGN_0007

hypothetical protein

PGN_0036

hypothetical protein
(transposase family
protein)

PGN_0070

hypothetical protein

gmk

guanylate kinase

PGN_1207

transport multidrug
efflux protein

PGN_0956

hypothetical protein

PGN_1258

cobalamin biosynthesis
protein

PGN_t002
2

tRNA-Gly

PGN_1797

hypothetical protein

PGN_1325

ABC transporter
membrane protein

PGN_t003
4

tRNA-Pro

hypothetical
protein(selenium
metabolism protein
YedF )
hypothetical protein
(outer membrane
protein)

oxidoreductase
Gfo/Idh/MocA
family
ABC transporter
permease

PGN_1061

hypothetical protein

PGN_0267

riboflavin biosynthesis
protein

PGN_1815

PGN_1086

hypothetical protein

PGN_0045

hypothetical protein

PGN_0973

PGN_t004
6

tRNA-Asp

PGN_1211

hypothetical protein

PGN_1967

sulfatase

lacZI

beta-galactosidase

PGN_t001
8

tRNA-Leu

PGN_0212

transposase in ISPg1

PGN_2050

ATP-dependent
helicase

PGN_0285

pyridine nucleotidedisulphide
oxidoreductase

PGN_1897

transport related
membrane protein

PGN_1956

putative DNA methylase

PGN_1838

partial transposase in
ISPg1

PGN_2090

hypothetical protein

PGN_1378

replicative DNA helicase

PGN_1389

acetyltransferase

PGN_1215

hypothetical protein

PGN_1952

hypothetical protein

PGN_1198

sodium-solute transporter

PGN_0435

partial hemagglutininrelated protein

PGN_1896

sugar transferase

PGN_0770

ribonuclease Z

PGN_0707

iron ABC transporter
permease

PGN_1629

hypothetical protein

traG

conjugate transposon
protein TraG

PGN_1009

PGN_1708

magnesium chelatase
subunit ChlI

PGN_1487

dephospho-CoA kinase

PGN_0425

partial transposase in
ISPg3

PGN_1821

PGN_1421

hypothetical protein

PGN_1474

S-ribosylhomocysteinase

PGN_0798

hypothetical protein

PGN_1747

hypothetical protein

PGN_0332

hypothetical protein

PGN_0855

hypothetical protein

PGN_t003
8

tRNA-Leu

PGN_0194

hypothetical protein

PGN_1145

hypothetical protein

PGN_1074

DNA
methyltransferase

PGN_1185

acetyltransferase

PGN_1195

hypothetical protein

NOL1/NOP2/sun family
protein
hypothetical protein
(cupin domain-containing
protein)

calciumtransporting
ATPase
putative integrin
subunit alpha

PGN_1538

cation efflux system

PGN_1528

PGN_1033

polysaccharide transport
protein

PGN_1639

PGN_2066

ABC transporter ATPbinding protein

PGN_2001

sensor histidine kinase

PGN_1690

exported fucosidase

PGN_0633

yadS protein

PGN_2028

hypothetical protein

PGN_0575

transposase in ISPg1

PGN_0686

iron ABC transporter
permease

PGN_0859

ABC transporter
permease protein

PGN_0644

transposase in ISPg1

PGN_1087

hypothetical protein

PGN_1766

hypothetical protein

PGN_0519

competence
protein

PGN_0325

hypothetical protein

PGN_0986

hypothetical protein

PGN_1584

potassium/proton
antiporter

PGN_1295

hypothetical protein

PGN_0870

rod shape-determining
protein RodA

PGN_0162

hypothetical protein

PGN_1765

hypothetical protein

prtQ

PrtQ, protease

PGN_1438

hypothetical protein

PGN_1790

hypothetical protein

PGN_1661

hypothetical protein

PGN_1939

D-tyrosyltRNA(Tyr)
deacylase

PGN_0030

beta-mannosidase

PGN_1481

polysaccharide
biosynthesis protein

PGN_0617

hypothetical protein

PGN_0689

hypothetical protein
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PGN_1214

RHS repeat-associated
core domain protein

PGN_1222

hypothetical protein

PGN_1499

hypothetical protein

PGN_1719

PGN_0708

iron ABC transporter ATPbinding protein

PGN_0074

hypothetical protein

PGN_1332

para-aminobenzoate
synthase component I

PGN_1194

PGN_1322

hypothetical protein

PGN_0130

PGN_0311

hypothetical protein

PGN_1731

hypothetical protein

PGN_0681

hypothetical protein

PGN_1475

PGN_1653

thiamine biosynthesis
lipoprotein ApbE

PGN_1462

hypothetical protein

PGN_0718

ABC transporter
permease protein

PGN_1923

hypothetical protein

PGN_1535

hypothetical protein

PGN_1459

hypothetical protein

PGN_1029

GtrA family protein

PGN_1949

hypothetical protein

PGN_0005

hypothetical protein

PGN_1279

partial transposase
in ISPg3

PGN_0878

hypothetical protein

PGN_0940

partial transposase in
ISPg2

lacZII

beta-galactosidase

PGN_0111

PGN_0512

biotin--acetyl-CoAcarboxylase ligase

PGN_0980

alpha-1,2-mannosidase

PGN_1227

TPR domain protein

PGN_1351

PGN_0849

hypothetical protein

PGN_0786

hypothetical protein

partial transposase in
ISPg1
5'-methylthioadenosine/Sadenosylhomocysteine
nucleosidase

Appr-1-p
processing protein
bifunctional UDPN-acetylmuramoyltripeptide:D-alanylD-alanine
ligase/alanine
racemase

partial transposase
in ISPg6
TetR family
transcriptional
regulator

PGN_0877

SNF2-related helicase

PGN_1386

conjugative transposon
TraJ protein

PGN_1928

CRISPR-associated Cmr5
family protein

PGN_1190

RNA methyltransferase

PGN_0506

hypothetical protein

PGN_0013

two-component
system sensor
histidine kinase

PGN_1681

ABC transporter ATPbinding protein

PGN_0307

TatD family protein

PGN_0908

hypothetical protein

PGN_0032

hypothetical protein

PGN_1083

hypothetical protein

PGN_0003

hypothetical protein

PGN_0703

hypothetical protein

PGN_1679

PGN_2011

helicase

PGN_0006

Na+driven multidrug
efflux pump

PGN_1801

putative
endonuclease

PGN_1192

PGN_0750

copper homeostasis
protein CutC

PGN_1072

glycosyl transferase
family 2

PGN_1709

hypothetical protein

PGN_0205

PGN_1898

transport protein

PGN_1310

glycogen synthase

PGN_1100

capsule biosynthesis
protein CapA

PGN_1983

ion transporter

PGN_1101

hypothetical protein

PGN_1944

hypothetical protein

PGN_1725

polysaccharide
deacetylase

PGN_1013

putative Fe-S
oxidoreductase

PGN_0270

amidophosphoribosyltransferase

PGN_0314

formate/nitrite transporter

PGN_1404

hypothetical protein

PGN_0869

penicillin-binding
protein 2

PGN_1985

N-acetylmuramoyl-Lalanine amidase

PGN_0699

hypothetical protein

PGN_1559

hypothetical protein

PGN_1267

SerB family protein

PGN_0327

DNA polymerase III
epsilon chain

PGN_1008

partial transposase in
ISPg1

PGN_0230

serine
acetyltransferase

PGN_1084

hypothetical protein

PGN_0844

hypothetical protein

PGN_t001
6

tRNA-Arg

PGN_0651

hypothetical protein

PGN_1915

PGN_1931

CRISPR-associated Cmr3
family protein

PGN_0554

hypothetical protein

PGN_0436

partial hemagglutininrelated protein

traA
PGN_0979

hypothetical protein

outer membrane
protein
DNA-binding
protein histone-like
family
AraC family
transcriptional
regulator

conjugative
transposon TraJ
protein
conjugal transfer
protein TraA

PGN_t002
0

tRNA-Pro

PGN_0147

putative lipoprotein

PGN_0071

PF11888 domain
protein

PGN_1483

hypothetical protein

PGN_1608

sialidase

PGN_0776

hypothetical protein

PGN_0556

cobalamin
biosynthesisrelated protein

PGN_0478

partial transposase in
ISPg4

PGN_0910

hypothetical protein

PGN_0719

ABC transporter
permease protein;

PGN_t001
5

tRNA-His

PGN_1076

DNA methylase

PGN_0579

hypothetical protein

PGN_0132

hypothetical protein

PGN_1427

hypothetical protein

PGN_0961

hypothetical protein

PGN_1919

hypothetical protein

PGN_1307

hypothetical protein

PGN_0926

hypothetical protein

PGN_0076

mobilization protein TraG
family

PGN_0286

PGN_1540

ABC transport
membrane protein

PGN_0848

hypothetical protein

PGN_0606

PGN_1289

hypothetical protein

PGN_0720

ABC transporter
permease protein

PGN_1440

vancomycin B-type
resistance protein
VanW

PGN_0352

hypothetical protein

hypothetical protein

PGN_1494

oxygenindependent
coproporphyrinoge
n III oxidase

PGN_0835

hypothetical protein

PGN_0430

ABC transporter
ATP-binding
protein

PGN_1720

PGN_0981

PGN_1463

hypothetical protein
Sadenosylmethionine:tRNA
ribosyltransferaseisomerase
phosphoribose
diphosphate:decaprenylphosphate
phosphoribosyltransferase

pyridine nucleotidedisulfide
oxidoreductase
glucosamine-6phosphate
deaminase-like
protein

PGN_0052

hypothetical protein

PGN_0061

putative conjugative
transposon protein

PGN_0339

truA

tRNA pseudouridine
synthase A

PGN_1290

hypothetical protein

PGN_0107

PGN_1932

CRISPR-associated Csm1
family protein

PGN_0943

alginate Oacetyltransferase

PGN_0677

PGN_0539

metallo-beta-lactamase
superfamily protein

PGN_1925

CRISPR-associated Cas1
family protein

PGN_1248

hypothetical protein

PGN_0745

hypothetical protein

PGN_0479

hypothetical protein

PGN_1133

hypothetical protein

PGN_0098

hypothetical protein

PGN_0222

conjugative
transposon TraJ
protein

PGN_0164

hypothetical protein

PGN_0340

carboxyl-terminal
processing protease

PGN_1738

long-chain-fatty-acid-CoA
ligase

PGN_0542

partial transposase in
ISPg2

PGN_0596

PGN_0951

conjugative transposon
TraJ protein

PGN_0553

hypothetical protein

PGN_1464
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partial transposase in
ISPg3
multi antimicrobial
extrusion protein
MatE

conjugate transposon
protein
HAD-superfamily
subfamily IB
hydrolase

PGN_0166

hypothetical protein
(transposase)

PGN_1073

hypothetical protein

PGN_1730

hypothetical protein

porS

membrane protein
PorS

PGN_1940

MazG nucleotide
pyrophosphohydrolase

PGN_0771

NLP/P60 family protein

PGN_1665

hypothetical protein

PGN_1147

hypothetical protein

PGN_0014

hypothetical protein

PGN_1070

hypothetical protein

xseA

exodeoxyribonuclease
VII large subunit

PGN_1824

putative integrin
subunit alpha

PGN_0582

DNA topoisomerase I

PGN_1071

methylthioribose kinase

PGN_0308

hypothetical protein

PGN_0018

hypothetical protein

PGN_1527

tetrapyrrole methylase

PGN_0146

hypothetical protein

PGN_0431

hypothetical protein

PGN_0863

DNA methylase N4/N-6

PGN_0046

hypothetical protein

PGN_1250

hypothetical protein

PGN_1682

ABC transporter
permease protein

PGN_1387

ABC transporter
permease protein;

PGN_0342

uracil-DNA glycosylase

PGN_1680

ABC transporter
permease protein

PGN_1495

low-specificity Lthreonine aldolase

PGN_1336

putative lipoprotein

PGN_t002
3

tRNA-Asp

PGN_0151

hypothetical protein

PGN_0923

DNA primase

PGN_0469

biotin synthesis
protein

PGN_0536

hypothetical protein

PGN_0338

hypothetical protein

PGN_1030

hypothetical protein

PGN_1201

tRNA (adenine-N6)methyltransferase

PGN_0862

Type III restriction
enzyme, res subunit

PGN_0845

hypothetical protein

PGN_1907

hypothetical protein

PGN_0480

partial transposase
in ISPg4

PGN_1953

TonB-dependent outer
membrane receptor

PGN_t000
5

tRNA-Val

PGN_1534

hypothetical protein

PGN_1683

ABC transporter
permease protein

PGN_0565

hypothetical protein

PGN_0822

hypothetical protein

PGN_0924

mobilization protein

PGN_1306

hypothetical protein

PGN_1920

hypothetical protein

PGN_1064

transposase in
ISPg3

PGN_0600

conjugal transfer
protein TraG

PGN_t000
2

tRNA-Asn

PGN_0538

hypothetical protein

PGN_0086
PGN_0417

DNA methylase
hypothetical protein

PGN_1223

uracil permease

PGN_0922

Virulence-associated
protein E

PGN_0051

hypothetical protein

PGN_1082

hypothetical protein

PGN_0584

topoisomerase

PGN_1473

PGN_0581

topoisomerase

PGN_t004
1

hypothetical protein
tRNA-Ser

traQ

conjugate transposon
protein TraQ

PGN_0362

hypothetical protein

PGN_1046

DNA repair protein

PGN_0787

hypothetical protein

PGN_1144

hypothetical protein

PGN_1234

hypothetical protein

PGN_2084

TraJ family protein
conjugative transpos

PGN_1918

hypothetical protein

PGN_0048

PcfK-like protein

PGN_0852

immunoreactive 47 kDa
antigen PG97

PGN_2063

hypothetical protein

PGN_0588

hypothetical protein

PGN_0555

hypothetical protein

PGN_0105

hypothetical protein

PGN_0957

hypothetical protein

PGN_0050

hypothetical protein

PGN_1461

spore maturation protein
A/B

PGN_1394

transposase in ISPg2

PGN_1292

anti-restriction protein

PGN_0946

hypothetical protein

PGN_1068

oxidoreductase
domain protein

PGN_0152

immunoreactive 61 kDa
antigen PG91

traO

conjugate transposon
protein TraO

PGN_1916

ABC transporter ATPbinding protein

PGN_1609

hypothetical protein

PGN_0839

transposase in ISPg2

PGN_1017

hypothetical protein

PGN_0075

relaxase/mobilization
nuclease domain p

PGN_1662

partial transposase
in ISPg3

PGN_1924

CRISPR-associated Cas2
family protein

PGN_1257

hypothetical protein

PGN_0652

hypothetical protein

PGN_0402

hypothetical protein

PGN_0851

hypothetical protein

PGN_1707

putative lipoprotein

PGN_1478

hypothetical protein

PGN_0442

PGN_0513

hypothetical protein

PGN_0559

hypothetical protein

PGN_1075

ISPg2, transposase

PGN_0949

PGN_0947

hypothetical protein

PGN_1291

conserved hypothetical
protein related to phage

PGN_0028

calcium-transporting
ATPase

PGN_1333

PGN_0383

transporter

PGN_1069

hypothetical protein

PGN_0306

hypothetical protein

PGN_0953

PGN_1825

hypothetical protein

PGN_1217

hydroxylamine reductase

PGN_0958

hypothetical protein

hmuR

TonB-dependent
receptor HmuR

PGN_1823

hypothetical protein

PGN_0455

partial transposase Orf1
in ISPg5

PGN_1476

hypothetical protein

PGN_1371

hypothetical protein

PGN_0601

hypothetical protein

transposase in
ISPg3
ABC transporter
ATP-binding
protein
paraaminobenzoate
synthase
component I
transposase in
ISPg3

PGN_1353

DNA alkylation repair
enzyme

PGN_0460

DNA-binding protein
histone-like family

PGN_1059

conjugative
transposon TraJ
protein

PGN_1089

methyltransferase

PGN_1067

hypothetical protein

PGN_0978

hypothetical protein

PGN_0072

hypothetical protein

PGN_1277

hypothetical protein

PGN_1368

hypothetical protein

PGN_1726

transposase in ISPg3

PGN_1917

ABC transporter
ATP-binding
protein

PGN_1624

hypothetical protein

PGN_1160

transposase in ISPg2

PGN_0441

htpG; heat shock
protein 90

PGN_r000
6

5S ribosomal RNA

PGN_t000
8

tRNA-Pro

PGN_2036

hypothetical protein

PGN_0825

hypothetical protein

PGN_0950

ABC transporter ATPbinding protein

PGN_1293

PcfK-like protein

PGN_1927

CRISPR-associated Cas1
family protein

PGN_0899

hypothetical protein

PGN_1748

cytochrome c
biogenesis protein
CcsA

PGN_0909

transposase in ISPg3

PGN_1922

transposase in ISPg3

PGN_1921

transcriptional
regulator

PGN_0796

hypothetical protein

PGN_1065

transposase in ISPg3

porR

porP protein

PGN_1109

hypothetical protein

PGN_0363

hypothetical protein

PGN_1490

precorrin-2 C20methyltransferase

PGN_1060

transposase in ISPg3

PGN_0856

A/G-specific adenine
glycosylase

PGN_0552

hypothetical protein

PGN_0954

partial transposase in
ISPg6

PGN_0920

partial excisionase

PGN_t001
7

tRNA-Ser

hypothetical protein

PGN_t000
4

tRNA-Val

PGN_1265

hypothetical protein

PGN_0948
PGN_0049

hypothetical protein
anti-restriction protein

PGN_1684
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PGN_0454

transposase in ISPg3

PGN_1335

PGN_1911

transposase in ISPg3

PGN_t002
4

PGN_1592

hypothetical protein

PGN_0879

PGN_0213

hypothetical protein

PGN_0790

transposase in ISPg3

hypothetical protein

PGN_1006

transposase in ISPg3

PGN_1228

hypothetical protein

tRNA-Phe

PGN_1063

partial transposase
Orf2 in ISPg5

PGN_0846

hypothetical protein

transposase in ISPg3

PGN_0843

hypothetical protein

PGN_t004
5

tRNA-Lys

PGN_0459

transposase in ISPg3

PGN_1334

hypothetical protein

PGN_0578

conjugate
transposon protein

PGN_0106

partial transposase in
ISPg3

PGN_0305

hypothetical protein

PGN_1294

hypothetical protein

PGN_r001
2

5S ribosomal RNA

hypothetical protein

PGN_1826

hypothetical protein

PGN_0945

TetR family
transcriptional
regulator

PGN_t002
7

tRNA-Met

PGN_1729

acetyltransferase

PGN_0401

hypothetical protein

PGN_0921

hypothetical protein

PGN_0326

DNA-binding protein
histone-like family

PGN_2059

hypothetical protein

PGN_0850

hypothetical protein

PGN_1237

hypothetical protein

mobilization protein

PGN_t002
5

tRNA-Leu

PGN_1477

hypothetical protein
tRNA-Met

PGN_0586

PGN_0934

transposase in ISPg3

PGN_0925

PGN_1066

transposase in ISPg3

PGN_0847

hypothetical protein

PGN_0019

hypothetical protein

PGN_t000
6

PGN_0955

transposase in ISPg3

PGN_0475

hypothetical protein

PGN_t000
7

tRNA-Met

PGN_0364

hypothetical protein

PGN_0558

transposase in ISPg3

PGN_0337

hypothetical protein

PGN_0474

hypothetical protein

PGN_1778

hypothetical protein

PGN_1278

partial transposase in
ISPg3

PGN_1428

transposase in ISPg3

PGN_0574

hypothetical protein

PGN_t001
9

tRNA-Arg

PGN_0576

hypothetical protein

PGN_1913

transposase in ISPg3

PGN_1414

hypothetical protein

PGN_0551

hypothetical protein

PGN_0944

transposase in ISPg3

PGN_1560

hypothetical protein

PGN_1266

hypothetical protein

PGN_0853

hypothetical protein

PGN_1912

partial transposase in
ISPg6

PGN_r000
7

5S ribosomal RNA

PGN_0821

hypothetical protein

PGN_r000
3

5S ribosomal RNA

PGN_0047

hypothetical protein

PGN_0585

transposase in ISPg3

PGN_1836

transposase in ISPg3

PGN_0304

hypothetical protein

PGN_0864

transposase in ISPg3

PGN_0589

hypothetical protein

Table shows gene ID number and name of all P. gingivalis genes that were down
regulated (< 0.6 fold) when exposed to CSE.
Differentially expressed genes - P. gingivalis ATCC 33277
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Figure 5: P. gingivalis ATCC 33277 differentially expressed genes in CSE
Genes differentially expressed in P. gingivalis were grouped into different
functional categories using DAVID and KEGG enrichment analysis software, A.
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Metabolism; B. Genetic information processing; C. Environmental information
processing; D. Transposases or partial transposases; E. DNA replication,
recombination and repair; F. Others and G. hypothetical or conserved hypothetical
proteins. Closed boxes represent up regulated genes in P. gingivalis (> 1.5 fold),
when exposed to CSE and open boxes represent down regulated genes in P.
gingivalis (< 0.6 fold), when exposed to CSE.
KEGG analysis for differentially expressed P. gingivalis genes
KEGG analysis was done on differentially expressed P. gingivalis genes to group
them into various functional categories. Genes in several essential pathways were
found to be differentially expressed. KEGG orthology system was used to generate
these pathways with increased number of differentially expressed genes, which
include glycolysis, citrate cycle, pyruvate metabolism, biosyntehsis of amino acids,
butanoate metabolism, ABC transporters and CAMP resistance pathway genes.
Several genes related to citrate cycle (PGN_1418, PGN_1529, PGN_1753,
PGN_1755, PGN_1880, PGN_0496, PGN_0498, PGN_1752, and PGN_1756),
Figure 6; pyruvate metabolism (PGN_0504, PGN_1755, PGN_1753, PGN_1529,
PGN_1418,

PGN_1880,

Figure

7);

glycolysis

(PGN_1695,

PGN_0173,

PGN_1418, PGN_1529, PGN_1753, PGN_1755, Figure 8); butanoate metabolism
(PGN_0496, PGN_0498, PGN_0724, PGN_0727, PGN_1172, PGN_1418,
PGN_1755, PGN_1753, PGN_1529, Figure 9); and cationic antimicrobial peptide
(CAMP) resistance (rgpB and rgpA) (Figure 10) pathways were found to be up
regulated in P. gingivalis upon CSE exposure. Genes related to ABC transporter
pathway

(PGN_1325,

PGN_1324,

PGN_1025,
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PGN_1387,

PGN_1471,

PGN_0706, PGN_0686, PGN_0707, PGN_0708, Figure 11) were found to be
down regulated when P. gingivalis was exposed to Cigarette smoke. In amino acid
biosynthesis pathway a few genes (PGN_0173, PGN_1695 and PGN_1080) were
up regulated and a few genes (PGN_1475, PGN_0230, PGN_1474 and
PGN_1495) were down regulated (Figure 12).

Figure 6: Citrate cycle pathway of P. gingivalis
Generated using KEGG orthology system and red boxes show differentially
regulated P. gingivalis genes involved in Citrate cycle when exposed to CSE.
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Figure 7: Pyruvate metabolism pathway of P. gingivalis
Generated using KEGG orthology system and red boxes show differentially
regulated P. gingivalis genes involved in Pyruvate metabolism when exposed to
CSE.
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Figure 8: Glycolysis pathway of P. gingivalis
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Generated using KEGG orthology system and red boxes show differentially
regulated P. gingivalis genes involved in Glycolysis when exposed to CSE.

Generated using KEGG orthology system and red boxes show differentially
regulated P. gingivalis genes involved in Glycolysis when exposed to CSE.

Figure 9: Butanoate metabolism pathway of P. gingivalis
Generated using KEGG orthology system and red boxes show differentially
regulated P. gingivalis genes involved in Butanoate metabolism when exposed to
CSE.
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Figure 10: CAMP resistance pathway of P. gingivalis
Generated using KEGG orthology system and red box shows differentially
regulated P. gingivalis genes RgpA and RgpB when exposed to CSE.

42

Figure 11: ABC transporter pathway of P. gingivalis
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Generated using KEGG orthology system and red boxes show differentially
regulated P. gingivalis ABC transporter genes when exposed to CSE.

Figure 12: Biosynthesis of amino acids pathway of P. gingivalis
Generated using KEGG orthology system and red boxes show differentially
regulated P. gingivalis genes involved in amino acid biosynthesis when exposed
to CSE.
F. alocis differentially expressed genes

44

When F. alocis was exposed to CSE, 83 genes were found to be differentially
expressed (P < 0.005); 72 genes were up regulated (> 1.5 fold) and 11 genes were
down regulated (< 0.6 fold). Many of the 83 genes that were differentially
expressed encode hypothetical proteins whose functions have yet to be
determined.
Up regulated genes include DNA replication gene (HMPREF0389_0155);
Transfer gene cluster (traE and traG); Genes in the ABC transporter operon
(HMPREF0389_00895,

HMPREF0389_00896,

HMPREF0389_00897,

HMPREF0389_01591,

HMPREF0389_01592,

HMPREF0389_01190,

HMPREF0389_01191 and HMPREF0389_01281); gene encoding fimbrial
assembly

protein

(HMPREF0389_00415);

transcription

regulator

genes

(HMPREF0389_00643, HMPREF0389_01102 and HMPREF0389_01590); gene
encoding cell wall serine protease (HMPREF0389_00110); nucleotide metabolism
gene (HMPREF0389_00826); genes responsible for Carbohydrate metabolism
(HMPREF0389_00473 and HMPREF0389_00883) and energy metabolism
(HMPREF0389_01302 and HMPREF0389_01303); gene encoding type IV pilus
protein (HMPREF0389_00416); several genes for processing genetic information
(e.g.,

HMPREF0389_00822,

HMPREF0389_00819,

HMPREF0389_00821,

HMPREF0389_00831,

HMPREF0389_00820,
HMPREF0389_00830,

HMPREF0389_00829, HMPREF0389_00828)
Table 5: List of up regulated genes in F. alocis upon CSE exposure
Gene ID

Gene name

Gene ID

Gene name

HMPREF0389_00155

DNA replication protein
DnaC

HMPREF0389_01736

rpmJ; psM;
Ribosomal
protein L36

HMPREF0389_00186

NlpC/P60 family
protein

HMPREF0389_01591

ABC transporter
permease
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Gene ID
HMPREF0389_01728
HMPREF0389_01281

Gene name
hypothetical;
Copper amine
oxidase domain
protein
ABC transporter
ATP-binding protein

HMPREF0389_00184

type IV conjugative
transfer system protein
TraE

HMPREF0389_01302

HMPREF0389_00178

TraG family protein

HMPREF0389_00820

HMPREF0389_00166

TnpX site-specific
recombinase

HMPREF0389_00825

HMPREF0389_00246

antirestriction protein
(ArdA)

HMPREF0389_00154
HMPREF0389_00969

V-type ATP
synthase beta
chain 2
DNA-directed
RNA polymerase
subunit alpha
map; Methionine
aminopeptidase

HMPREF0389_00412

hypothetical

HMPREF0389_01273

46unctional46l
membrane protein

HMPREF0389_01581

hlyD; hemolysin D

HMPREF0389_00826

adk; adenylate
kinase

HMPREF0389_00830

rpsE: 30S
ribosomal protein
S5

replication initiator
protein

HMPREF0389_00896

zinc ABC
transporter
permease

HMPREF0389_00415

fimbrial assembly
protein PilN

nitrite transporter NirC

HMPREF0389_00414

hypothetical

HMPREF0389_03101

23S ribosomal RNA

HMPREF0389_00831

50S ribosomal
protein L18

HMPREF0389_01537

hypothetical

HMPREF0389_03107

23S ribosomal RNA

HMPREF0389_00413

hypothetical

HMPREF0389_00416

pilM; type IV pilus
assembly protein

HMPREF0389_00505

Omethyltransferase
family protein

HMPREF0389_01169

CRISPR-associated
protein, Csd1 family

transcriptional
regulator, TetR
calcium-binding
acidic-repeat
protein
Transcriptional
regulator, AraC
ribH; 6,7dimethyl-8ribityllumazine
synthase
ribBA; 3,4dihydroxy-2butanone 4phosphate
synthase
preprotein
translocase
subunit SecY
rplQ; 50S
ribosomal protein
L17
zinc ABC
transporter ATPbinding protein

HMPREF0389_01685

hypothetical

HMPREF0389_01102

HMPREF0389_00162

conjugation protein

HMPREF0389_01448

HMPREF0389_01096

MATE efflux family
protein

HMPREF0389_01590

HMPREF0389_00644

FtsK/SpoIIIE family
protein

HMPREF0389_00882

HMPREF0389_01592

ABC transporter
permease, ATPbinding protein

HMPREF0389_00881

HMPREF0389_00823

Translation initiation
factor IF-1

HMPREF0389_00827

HMPREF0389_00879

riboflavin biosynthesis
protein RibD

HMPREF0389_00819

HMPREF0389_00824

hypothetical protein

HMPREF0389_00895

HMPREF0389_01079

Iron-sulfur clusterbinding protein

HMPREF0389_01191

ABC transporter
ATP-binding
protein

HMPREF0389_00883

HMPREF0389_00828

rplO; 50S
ribosomal protein
L15

HMPREF0389_03104

23S ribosomal RNA

HMPREF0389_03110

23S ribosomal
RNA

HMPREF0389_01135

hypothetical

HMPREF0389_01303

HMPREF0389_00897

V/A-type H+transporting ATPase
subunit D
Environmental sensor;
manganese/zinc/iron
transport system
permease protein

HMPREF0389_01190

HMPREF0389_01744

hypothetical

HMPREF0389_00829

rpmD; 50S
ribosomal protein
L30

HMPREF0389_00928

HMPREF0389_00643

transcriptional
regulator

HMPREF0389_01138

GTP binding
protein

HMPREF0389_00473

HMPREF0389_00822

rpsM; 30S ribosomal
protein S13

HMPREF0389_01110

prtA: cell wall
serine protease

HMPREF0389_01189

HMPREF0389_00898
HMPREF0389_00821

GNAT family
acetyltransferase
rpsK; 30S ribosomal
protein S11

hypothetical

HMPREF0389_01137

HMPREF0389_00660

NlpC/P60 family
protein

HMPREF0389_00959

efflux ABC
transporter
permease
HAD-superfamily
hydrolase
(46unctional partner
with ribBA and ribH)

fabZ; betahydroxyacyl-(acylcarrier-protein)
dehydratase
pyruvate
carboxylase
RND family efflux
transporter MFP
subunit
thiH; thiazole
biosynthesis protein
NADH oxidase,
water-forming

Table shows gene ID number and name of all F. alocis genes that were up
regulated (> 1.5 fold) when exposed to CSE.
Down regulated genes include gene encoding nitrate/nitrite response
regulator

protein

(HMPREF0389_00802);
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signal

peptidase

gene

(HMPREF0389_00799)

and

a

gene

responsible

for

glycolysis

(HMPREF0389_00226).
Table 6: List of down regulated genes in F. alocis upon CSE exposure
Gene ID

Gene name

HMPREF0389_00226

acetyl coenzyme A synthetase

HMPREF0389_00802

Nitrate/nitrite response regulator protein

HMPREF0389_01749

hypothetical

HMPREF0389_01748

hypothetical

HMPREF0389_01188

hypothetical

HMPREF0389_01353

amidinotransferase

HMPREF0389_00486

hypothetical

HMPREF0389_00798

hypothetical

HMPREF0389_00799

signal peptidase I

HMPREF0389_00801

hypothetical

HMPREF0389_00800

low density lipoprotein receptor 2

Table shows gene ID number and name of all F. alocis genes that were down
regulated (< 0.6 fold) when exposed to CSE.
Differentially expressed genes in F. alocis ATCC 35896
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Figure 13: F. alocis ATCC 35896 differentially expressed genes in CSE
Genes differentially expressed in F. alocis were grouped into different functional
categories using KEGG enrichment analysis software, A. Carbohydrate
metabolism; B. Energy metabolism; C. Lipid metabolism; D. Nucleotide
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metabolism; E. Metabolism of Cofactors and vitamins; F. Trancription; G.
Translation; H. Folding, sorting and degradation; I. Membrane transport; J.
Hypothetical proteins and K. Others. Closed boxes represent up regulated genes
in F. alocis (> 1.5 fold), when exposed to CSE and open boxes represent down
regulated genes in F. alocis (< 0.6 fold), when exposed to CSE.
KEGG analysis for differentially expressed F. alocis genes
KEGG analysis was done on differentially expressed F. alocis genes to group them
into various functional categories. Genes in several essential pathways were found
to differentially expressed. KEGG orthology system was used to generate these
pathways with increased number of differentially expressed genes, which include
pyruvate metabolism, oxidative phosphorylation, ABC transporter, protein export
and bacterial secretory system pathways. Genes related to oxidative
phosphorylation (HMPREF0389_01302 and HMPREF0389_01303, Figure 14),
ABC

transporter

HMPREF0389_00895,

(HMPREF0389_00896,
Figure

15)

and

HMPREF0389_00897
bacterial

secretory

and
system

(HMPREF0389_01581 and HMPREF0389_00827, Figure 16) pathways were up
regulated when F. alocis was exposed to Cigarette smoke. In protein export
pathway

gene

(HMPREF0389_00827)

was

up

regulated

and

gene

(HMPREF0389_00799) was down regulated (Figure 17). Similarly, in pyruvate
metabolism pathway gene (HMPREF0389_00473) was up regulated and gene
(HMPREF0389_00226) was down regulated (Figure 18) in F. alocis upon CSE
exposure.
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Figure 14: Oxidative phosphorylation pathway of F. alocis
Generated using KEGG orthology system and red boxes show differentially
regulated F. alocis genes involved in oxidative phosphorylation when exposed to
CSE.
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Figure 15: ABC transporter pathway of F. alocis
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Generated using KEGG orthology system and red boxes show differentially
regulated F. alocis ABC transporter genes when exposed to CSE.

Figure 16: Bacterial secretory system pathway of F. alocis
Generated using KEGG orthology system and red boxes show differentially
regulated F. alocis genes involved in secretion system when exposed to CSE.
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Figure 17: Protein export in F. alocis
Generated using KEGG orthology system and red boxes show differentially
regulated F. alocis genes involved in protein export when exposed to CSE.
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Figure 18: Pyruvate metabolism pathway of F. alocis
Generated using KEGG orthology system and red boxes show differentially
regulated F. alocis genes involved in Pyruvate metabolism when exposed to CSE.
T. denticola differentially expressed genes
We were unable to efficiently isolate RNA from T. denticola, therefore differentially
regulated genes could not be identified.
Validation of RNA-Seq data by qPCR analysis
To validate the RNA-Seq analysis, qPCR was performed on selected up regulated
and down regulated genes for both F. alocis and P. gingivalis. As seen in Table 7
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and Table 8, most of the selected genes showed trends similar to that of RNA-Seq
analysis. However differential expression of only a small number of genes was
statistically significant in the qPCR experiments.
Table 7: qPCR expression values for selected P. gingivalis genes

Gene ID

Gene name

16s rRNA

Reference gene

Control
qPCR
expression
value (Mean
CT)

CSE
qPCR
expression
value (Mean
CT)

P- value
(T- test)

10.73

13.17

0.0001

Selected P. gingivalis up-regulated genes by qPCR analysis
Gene ID
PGN_1047

a

PGN_0295

a

Kgp

a

PGN_1367

a

PGN_1740

a

RgpA

a

PGN_0727

a

PGN_1695

a

RpoC
Dps

a

a

PGN_0173

a

PGN_0175

a

PGN_1080

a

PGN_0660

a

PGN_0724

a

Gene ID

ΔCt
Value
(control)

ΔCt
Value
(CSE)

Delta Delta
Ct (DDCt)
Value

Fold
change
-DDCt
(2
)

Pvalue
(T- test)

hydroxylamine reductase

4.77

3.09

-1.68

3.2

0.16

C-terminal domain of Arg- and
Lys-gingipain proteinase

5.41

3.38

-2.03

4.08

0.23

Lys-gingipain

4.37

2.04

-2.33

5.02

0.58

glutamate dehydrogenase

4.75

2.86

-1.89

3.70

0.06

RNA polymerase ECF-type
sigma factor

3.61

2.50

-1.11

2.15

0.2

RgpAc; glycosyltransferase

3.87

1.23

-2.64

6.23

0.125

3.29

0.98

-2.31

4.95

0.013

3.52

1.12

-2.4

5.27

0.56

4.25

1.28

-2.97

7.83

0.01

4.07

1.17

-2.9

7.46

0.0009

3.77

1.13

-2.64

6.23

0.035

4.01

1.13

-2.88

7.36

0.022

3.66

1.1

-2.56

5.89

0.126

3.94

1.12

-2.82

7.06

0.0001

Gene name

4-hydroxybutyryl-CoA
dehydratase
fructose-1,6-bisphosphate
aldolase
DNA-directed RNA
polymerase subunit beta
DNA-binding protein from
starved cells Dps
glyceraldehyde 3-phosphate
dehydrogenase type I
2-ketoisovalerate ferredoxin
reductase
branched-chain amino acid
aminotransferase
alkyl hydroperoxide reductase

NAD-dependent 4hydroxybutyrate
4.13
1.24
-2.89
7.41
dehydrogenase
Selected P. gingivalis down-regulated genes by qPCR analysis
Gene name

ΔCt
Value
(control)
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ΔCt
Value
(cse)

Delta Delta Ct
(DDCt) value

Fold
change
-DDCt
(2
)

b

b

b

b

0.008*

Pvalue
(T- test)

PGN_1644

b

transposase in ISPg1

2.54

1.51

-1.03

2.04

0.01

uracil
phosphoribosyltransferase

4.97

5.87

0.9

0.53

0.0003

biotin synthetase

5.53

5.89

0.36

0.77

0.001

b

PGN_0885

nitroimidazole resistance
protein

5.83

5.79

-0.04

1.02

0.022

b

PGN_0545

sulfatase

5.88

5.63

-0.25

1.18

0.056

Upp

a

PGN_0134

a

b

The table shows all P. gingivalis up-regulated and down-regulated genes from
RNA-Seq selected for qPCR analysis. Positive DDCt values indicate more PCR
cycles and therefore less targeted gene after CSE exposure, meaning suppression
of targeted gene expression. Conversely, negative DDCt values indicate more
targeted gene after CSE exposure, indicating induction of gene expression.
a. Differentially expressed genes in qPCR which correlate with RNA-Seq results.
b. Represents P. gingivalis genes that showed statistically significant (P< 0.05)
difference in their expression when exposed to cigarette smoke in qPCR analysis.
Table 8: qPCR expression values for selected F. alocis genes
Gene ID

Gene name

16srRNA

Reference gene

Control
qPCR expression value
(Mean CT)

CSE
qPCR expression value (Mean
CT)

Pvalue
(Ttest)

10.54

11.23

0.16

Selected F. alocis up-regulated genes by qPCR analysis
Gene ID

Gene name

HMPREF0389_00155
HMPREF0389_00186

a

HMPREF0389_00184

a

HMPREF0389_00178
HMPREF0389_00166

a

HMPREF0389_00246

a

HMPREF0389_00154

a

HMPREF0389_00969
HMPREF0389_00162

a

HMPREF0389_01096

a

HMPREF0389_00644

a

DNA replication
protein DnaC
Nlpc/P60 family
protein
Type IV conjugative
transfer protein TraE
TraG family protein
TnpX site-specific
recombinase
Antirestriction protein
(ArdA)
Replication initiation
protein
Nitrate transporter
NirC
Conjugation protein
MATE efflux family
protein
FtsK/SpoIIIE family
protein

ΔCt
Value
(control)

ΔCt
Value
(CSE)

Delta Delta
Ct (DDCt)
Value

Fold
change
-DDCt
(2
)

Pvalue
(Ttest)

12.97

14.90

1.93

0.26

0.01

15.47

14.7

-0.77

1.70

0.64

15.79

14.65

-1.14

2.20

0.04

b

15.66

15.74

0.08

0.94

0.03

b

14.38

13.28

-1.1

2.14

14.24

13.43

-0.81

1.75

0.50

12.21

11.32

-0.89

1.85

0.71

8.41

9.1

0.69

0.61

0.01

13.26

12.58

-0.68

1.60

0.98

9.06

8.18

-0.88

1.84

0.84

11.18

10.42

-0.76

1.69

0.88
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b

0.13

b

HMPREF0389_01592

a

HMPREF0389_00823
HMPREF0389_00879

a

HMPREF0389_01079

Gene ID

HMPREF0389_00226

a

HMPREF0389_01353
a

HMPREF0389_00800

b

7.72

0.01

0.93

0.11

1.29

0.5

0.46

0.1

ΔCt
Value
(control)

ΔCt
Value
(CSE)

Delta Delta Ct
(DDCt) Value

Fold
change
-DDCt
(2
)

Pvalue
(Ttest)

4.61

4.71

0.1

0.93

0.02

9.95

9.49

-0.46

1.37

0.27

Amidinotransferase

13.17

12.54

-0.63

1.54

0.75

Signal peptidase I

8.39

8.77

0.38

0.98

0.02

Low density
lipoprotein receptor
2

8.93

8.72

-0.21

1.15

0.09

Gene name

HMPREF0389_00802

HMPREF0389_00799

ABC transporter
permease, ATP8.46
5.51
-2.95
binding protein
Translation initiation
4.12
4.21
0.09
factor IF-1
Riboflavin
biosynthesis protein
10.78
10.41
-0.37
RibD
Iron-sulfur cluster10.56
11.66
1.1
binding protein
Selected F. alocis down-regulated genes by qPCR analysis

Acetyl coenzyme A
synthetase
Nitrate/nitrite
regulator protein

Table shows all F. alocis up regulated and down regulated genes from RNA-Seq
selected for qPCR analysis. Positive DDCt values indicate more PCR cycles and
therefore less targeted gene after CSE exposure, meaning suppression of targeted
gene expression. Conversely, negative DDCt values indicate more targeted gene
after CSE exposure, indicating induction of gene expression.
a. Differentially expressed genes in qPCR which correlate with RNA-Seq results.
b. Represents the F. alocis genes that showed statistically significant (P<0.5)
difference in their expression when exposed to cigarette smoke in qPCR analysis.
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CHAPTER 4: DISCUSSION
Cigarette smoke is an important environmental risk factor for periodontal diseases.
Also cigarette smoke is known to increase vulnerability to oral bacterial infection,
but with reduced clinical signs of overt inflammation. The underlying mechanism
for this response is not clearly established. However, we can hypothesize that
cigarette smoke causes alterations in the gene expression in periodontal bacteria.
In our RNA-Seq experiments we were able to find the differentially expressed
genes in an established periodontal pathogen, P. gingivalis, and an emerging
periodontal pathogen, F. alocis. Approximately, 30% of genes in P. gingivalis
genome and 5% of genes in F. alocis genome were found to be differentially
expressed when exposed to cigarette smoke.
In P. gingivalis several functionally related genes were found to be up
regulated, including genes encoding arginine and lysine gingipains (kgp, rgpA and
rgpB), DNA binding genes and genes responsible for carbohydrate and energy
metabolism. Gingipains play an important role in multiple virulence mechanisms in
P. gingivalis, which are responsible for the growth and survival of the bacterium.
They protect P. gingivalis from phagocytosis by PMN’s by degrading macrophage
CD14, thus inhibiting activation of leucocytes through the LPS receptor (138) and
by degrading complement factor C3, preventing deposition of C3b on the bacterial
cell surface (225,226). Also in addition to providing energy through degradation
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and metabolism of extracellular matrix proteins (227), they subvert the host
response by degrading inflammatory cytokines, IL-6, IL-8 and TNF (136,138). DNA
binding gene PGN_1740 is known to play a key role in biofilm formation by P.
gingivalis (228). It has been demonstrated that the Dps (DNA-binding protein from
starved cells) protein in E. coli plays an important role in the protection of cells from
peroxide stress and is believed to have similar kind of function in P. gingivalis
(229,230,231). Carbohydrate and amino acid metabolism provide P. gingivalis with
energy necessary for its growth.
Several

genes

encoding

proteins

involved

in

DNA

replication,

recombination and repair which are essential genes for P. gingivalis; transfer (tra)
genes which might be responsible for genomic diversity in P. gingivalis strains
(232,233); ABC transport genes required for optimal entry of P. gingivalis into
GECs (234); genes in the capsular biosynthesis locus (PGN_110 and PGN_1072)
needed for capsule synthesis; minor fimbrial operon gene (mfa1) which is known
to play

key role in P. gingivalis auto-aggregation (235) and interspecies

interactions with oral streptococci that facilitate biofilm formation (97,236), were
found to be down regulated when P. gingivalis was exposed to cigarette smoke
extract.
Many of the differentially expressed genes in F. alocis when exposed to
CSE conditioned media encode hypothetical proteins whose function is yet to be
determined. Several ABC transporter genes were found to be up regulated which
are believed to provide resistance to P. gingivalis from potentially harmful
chemicals in cigarette smoke (222) and might have similar function in F. alocis.
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Transfer (tra) genes necessary for non-sexual transfer of genetic material in both
Gram-positive and Gram-negative bacteria (237) and several genes processing
genetic information were induced when exposed to cigarette smoke, suggesting
the potential for increased genomic diversity among F. alocis strains. A fimbrial
assembly gene (HMPREF0389_00415) which is known for its virulence in other
bacteria like P. gingivalis, E. coli and also several carbohydrate and lipid
metabolism genes that provide energy to the organism were found to be up
regulated. Nitrate/nitrite response regulator protein (HMPREF0389_00802)
needed for alternative mode of amino acid synthesis (169) was seen to be down
regulated when exposed to cigarette smoke.
Even though all selected up regulated P. gingivalis genes from RNA-Seq
showed up regulation (fold change > 1.5) in their expression when exposed to
CSE in qPCR analysis, there were only a few genes with significant (P≤0.01)
differences, which include PGN_0724, dps, rpoC and PGN_0660. DNA- binding
genes (dps and rpoC) were seen to show increased expression in both RNA-Seq
and qPCR analysis when exposed to CSE. These proteins bind DNA and are
known as histone-like proteins and are believed to have diversity of functions
responsible for survival of the organism. Also as said earlier Dps (DNA-binding
protein from starved cells) protein in E. coli plays an important role in the protection
of cells from peroxide stress and might show similar function in P. gingivalis
(222,223,224). PGN_0660 and PGN_0724 are oxidoreductases and increase in
the expression of these gene may be involved in protecting the bacteria from
oxidative stress generated in periodontal diseases.
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In contrast with our RNA-Seq data, only one gene Upp (uracil phospho
ribosyl transferase) which might be responsible for cell wall organization and
regulation of cell wall shape was found to be down regulated (Fold change < 0.6)
in qPCR analysis.
Similar to RNA-Seq results most of the selected up regulated F. alocis
genes from were found to be up regulated (Fold change >1.5) in qPCR analysis,
but only expression of few genes was statistically significant (P≤0.01) difference,
which include HMPREF0389_00969 and HMPREF0389_01592. Formate/ Nitrate
transporter protein (HMPREF0389_00969) may be necessary for the anaerobic
respiration of F. alocis. ABC transporter protein (HMPREF0389_01592) was seen
to be up regulated in both qPCR and RNA-Seq analysis of F. alocis genes. As said
earlier, this gene is believed to responsible for protecting P. gingivalis from harmful
chemicals of cigarette smoke (222) and it might have similar function in F. alocis.
In contrast with our RNA-Seq data, most of the selected F. alocis down
regulated

genes

remain

unaltered

in

qPCR

analysis.

One

gene

HMPREF0389_01353 (amidino transferase) found to be up regulated in qPCR and
downregulated in RNA-Seq. It’s function in the virulence of F. alocis was yet to be
determined.
As stated earlier, expression of most of the selected genes for qPCR was similar
to that of RNA-seq but not statistically significant (P≤0.01). This might be due to
limitations in qPCR, like intra- and inter- assay variability (238) and/or complicated
RNA-Seq technique. As statistical power is closely linked to sample size, a long
transcript is more likely to be found differentially expressed during RNA-Seq than
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a short transcript (240). So expression levels of short genes are not accurate with
RNA-Seq analysis (239).
Also our RNA-seq data for P. gingivalis is not in agreement with the study
done by Bagaitkar et al.. (222). Several genes responsible for growth and survival
of P. gingivalis like genes responsible for DNA- replication, recombination and
repair; ABC transporter genes which were found to be up regulated in her study,
were down regulated in our study. Study done by Bagaitkar et al.. (222) was on P.
gingvalis W83 strain, by using microarray analysis and at a CSE concentration of
500 ng/ml nicotine equivalents. We used P. gingivalis ATCC 33277 and a CSE
concentration of 1000 ng/ml nicotine equivalency and RNA sequencing. Therefore,
genetic, dose and technical differences may each and all have contributed to
variation in results between studies.
Future studies can be done on the key P. gingivalis and F. alocis
differentially expressed genes (validated by qPCR), when exposed to CSE
conditioned media, using site-directed mutagenesis and complement assays.
These procedures provide better understanding of specific genes as well as for
developing novel variants of gene of interest. These studies might also provide
some of the first insights into how tobacco smoke changes the P. gingivalis and F.
alocis phenotype in a manner likely to promote their colonization and infection.
In summary, smokers are more prone to bacterial infection and to develop
periodontitis, yet exhibit reduced clinical inflammation. Our experimental results
showed that several genes essential for growth and survival of P. gingivalis and F.
alocis were differentially expressed when exposed to cigarette smoke. These
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results may explain in part the altered virulence and host-pathogen interactions.

62

REFERENCES
1. Jong-wook., L. (2003). World Health Organization director general’s speech to
12th
World
Congress
on
Tobacco
and
Health.
Available
at:
http://www.who.int/dg/lee/speeches/2003/helsinki/en.
2. U.S. Department of Health and Human Services (2014). The Health
Consequences of Smoking—50 Years of Progress: A Report of the Surgeon
General. Atlanta: U.S. Department of Health and Human Services, Centers for
Disease Control and Prevention, National Center for Chronic Disease Prevention
and Health Promotion, Office on Smoking and Health.
3. Xu, X., et al.. (2015). Annual healthcare spending attributable to cigarette
smoking: an update. Am J Prev Med 48(3): 326-333.
4. Rodgman, A. & Cook, L. (2014). The Composition of Cigarette Smoke. An
Historical Perspective of Several Polycyclic Aromatic Hydrocarbons. Beiträge zur
Tabakforschung / Contributions to Tobacco Research, 23(6), pp. 384-410.
Retrieved 22 Apr. 2016, from doi:10.2478/cttr-2013-0873
5. Wang, L. Y., et al.. (1998). 4-Aminobiphenyl DNA damage in liver tissue of
hepatocellular carcinoma patients and controls. Am J Epidemiol 147(3): 315-323.
6. Burns, D. N., Kramer, A., Yellin, F., Fuchs, D., Wachter, H., Digioia, R. A.,
Goedert, J. J. (1991). Cigarette Smoking. Journal of Acquired Immune Deficiency
Syndromes, 4(1). doi:10.1097/00126334-199101000-00011
7. Al-Sayed, E. M. and K. S. Ibrahim (2014). Second-hand tobacco smoke and
children. Toxicol Ind Health 30(7): 635-644.
8. Bi, X., Sheng, G., Feng, Y., Fu, J., & Xie, J. (2005). Gas- and particulate-phase
specific tracer and toxic organic compounds in environmental tobacco smoke
[Abstract].
Chemosphere,
61(10),
1512-1522.
doi:10.1016/j.chemosphere.2005.04.057
9. Perfetti, T., & Rodgman, A. (2008). The Chemical Components of Tobacco and
Tobacco Smoke. doi:10.1201/9781420078848
10. Mishra, A., Chaturvedi, P., Datta, S., Sinukumar, S., Joshi, P., & Garg, A.
(2015). Harmful effects of nicotine. Indian Journal of Medical and Pediatric

63

Oncology: Official Journal of Indian Society of Medical & Pediatric Oncology, 36(1),
24–31
11. Furrukh, M. (2013). Tobacco Smoking and Lung Cancer: Perception- changing
facts. Sultan Qaboos University Medical Journal, 13(3), 345–358.
12. Sasco, A., Secretan, M., & Straif, K. (2004). Tobacco smoking and cancer: A
brief review of recent epidemiological evidence. Lung Cancer, 45.
doi:10.1016/j.lungcan.2004.07.998.
13. Bagaitkar, J., Demuth, D. R., & Scott, D. A. (2008). Tobacco use increases
susceptibility to bacterial infection. Tobacco Induced Diseases, 4(1), 12.
doi:10.1186/1617-9625-4-12
14. Ezzati, M., et al.. (2005). Role of smoking in global and regional cardiovascular
mortality. Circulation. 112(4): p. 489-97.
15. Mercado, C., & Jaimes, E. A. (2007). Cigarette smoking as a risk factor for
atherosclerosis and renal disease: Novel pathogenic insights. Current Science Inc
Current Hypertension Reports, 9(1), 66-72. doi:10.1007/s11906-007-0012-8
16. Yadav, D., & Whitcomb, D. C. (2010). The role of alcohol and smoking in
pancreatitis. Nature Reviews Gastroenterology & Hepatology , 7(3), 131-145.
doi:10.1038/nrgastro.2010.6
17. Smyk, D.S., et al.. (2012). Smoking as a risk factor for autoimmune liver
disease: what we can learn from primary biliary cirrhosis. Ann Hepatol. 11(1): p. 714.
18. Baelum, V., & Lopez, R. (2003). Defining and classifying periodontitis: Need
for a paradigm shift? European Journal of Oral Sciences, 111(1), 2-6.
doi:10.1034/j.1600-0722.2003.00014.x
19. Pihlstrom, B. L., Michalowicz, B. S., & Johnson, N. W. (2005). Periodontal
diseases. The Lancet, 366(9499), 1809-1820. doi:10.1016/s0140-6736(05)677288
20. Huttunen, R., Heikkinen, T., & Syrjänen, J. (2010). Smoking and the outcome
of infection. Journal of Internal Medicine, 269(3), 258-269. doi:10.1111/j.13652796.2010.02332.x
21. Arcavi, L., & Benowitz, N. L. (2004). Cigarette Smoking and Infection. Archives
of Internal Medicine, 164(20), 2206. doi:10.1001/archinte.164.20.2206
22. Marcy, M. (1987). Cigarette smoking and respiratory tract infection. Clin Chest
Med.8381- 391

64

23. Richardson, M. (1988). Upper airway complications of cigarette smoking.
Journal of Allergy and Clinical Immunology, 81(5), 1032-1035. doi:10.1016/00916749(88)90175-3
24. Dales, L. G., Friedman, G. D., Siegelaub, A., & Seltzer, C. C. (1974). Cigarette
smoking and serum chemistry tests. Journal of Chronic Diseases, 27(6), 293-307.
doi:10.1016/0021-9681(74)90093-9
25. Gulsvik, A., & Fagerhol, M. (1979). Smoking and Immunoglobulin Levels. The
Lancet, 313(8113), 449. doi:10.1016/s0140-6736(79)90934-6
26. Gerrard, J. W., et al.. (1980). Immunoglobulin levels in smokers and nonsmokers. Ann Allergy 44(5): 261-262.
27. Andersen, P., Pedersen, O. F., Bach, B., & Bonde, G. J. (1982). Serum
antibodies and immunoglobulins in smokers and nonsmokers. Clinical and
Experimental Immunology, 47(2), 467–473.
28. Finklea, J. F., Hasselblad, V., Riggan, W. B., Nelson, W. C., Hammer, D. I., &
Newill, V. A. (1971). Cigarette Smoking and Hemagglutination Inhibition Response
to Influenza after Natural Disease and Immunization 1. American Review of
Respiratory Disease, 104(3), 368-376. doi:10.1164/arrd.1971.104.3.368
29. Gruchow, H. W., Hoffmann, R. G., Marx, J. J., Emanuel, D. A. and Rimm, A.
A. (1981). Precipitating Antibodies to Farmer's Lung Antigens in a Wisconsin
Farming Population. American Review of Respiratory Disease, Vol. 124, No. 4
(1981), pp. 411-415.
30. Ginns, L. C., Goldenheim, P. D., Burton, R. C., Colvin, R. B., Miller, L. G.,
Goldstein, G., Kazemi, H. (1982). T-lymphocyte subsets in peripheral blood and
lung lavage in idiopathic pulmonary fibrosis and sarcoidosis: Analysis by
monoclonal antibodies and flow cytometry. Clinical Immunology and
Immunopathology, 25(1), 11-20. doi:10.1016/0090-1229(82)90160-x
31. Miller, L. G., Goldstein, G., Murphy, M., & Ginns, L. C. (1982). Reversible
Alterations in Immunoregulatory T Cells in Smoking. Chest, 82(5), 526-529.
doi:10.1378/chest.82.5.526
32. Reinherz, E. L., Rubinstein, A., Geha, R. S., Strelkauskas, A. J., Rosen, F. S.,
& Schlossman, S. F. (1979). Abnormalities of Immunoregulatory T Cells in
Disorders of Immune Function. New England Journal of Medicine, 301(19), 10181022. doi:10.1056/nejm197911083011902
33. Noble, R. C., & Penny, B. B. (1975). Comparison of leukocyte count and
function in smoking and nonsmoking young men. Infection and Immunity, 12(3),
550–555.

65

34. Corberand, J., Nguyen, F., Do, A. H., Dutau, G., Laharrague, P., Fontanilles,
A. M., & Gleizes, B. (1979). Effect of tobacco smoking on the functions of
polymorphonuclear leukocytes. Infection and Immunity, 23(3), 577–581.
35. Wewers, M. D., Diaz, P. T., Wewers, M. E., Lowe, M. P., Nagaraja, H. N., &
Clanton, T. L. (1998). Cigarette Smoking in HIV Infection Induces a Suppressive
Inflammatory Environment in the Lung. American Journal of Respiratory and
Critical Care Medicine, 158(5), 1543-1549. doi:10.1164/ajrccm.158.5.9802035
36. Twigg, H. L., Soliman, D. M., & Spain, B. A. (1994). Impaired alveolar
macrophage accessory cell function and reduced incidence of lymphocytic
alveolitis in HIV-infected patients who smoke. Aids, 8(5), 611-618.
doi:10.1097/00002030-199405000-00006
37. Schroeter, M. R., Sawalich, M., Humboldt, T., Leifheit, M., Meurrens, K.,
Berges, A., . . . Schaefer, K. (2008). Cigarette Smoke Exposure Promotes Arterial
Thrombosis and Vessel Remodeling after Vascular Injury in Apolipoprotein EDeficient
Mice.
Journal
of
Vascular
Research,
45(6),
480-492.
doi:10.1159/000127439
38. Wolf, P. A. (1988). Cigarette smoking as a risk factor for stroke. The
Framingham Study. JAMA: The Journal of the American Medical Association,
259(7), 1025-1029. doi:10.1001/jama.259.7.1025
39. Bjartvelt, K., Tverdal, A. (2005). Health consequences of smoking 1–4
cigarettes per day. Tob Control 2005;14:315-320 doi:10.1136/tc.2005.011932
40. Csordas, A., & Bernhard, D. (2013). The biology behind the atherothrombotic
effects of cigarette smoke. Nature Reviews Cardiology, 10(4), 219-230.
doi:10.1038/nrcardio.2013.8
41. Bullen, C. (2008). Impact of tobacco smoking and smoking cessation on
cardiovascular risk and disease. Expert Review of Cardiovascular Therapy, 6(6),
883-895. doi:10.1586/14779072.6.6.883
42. Stämpfli, M. R., & Anderson, G. P. (2009). How cigarette smoke skews immune
responses to promote infection, lung disease and cancer. Nature Reviews
Immunology, 9(5), 377-384. doi:10.1038/nri2530
43. Martins Junior, E. V., et al.. (1996). Smoking and inflammatory bowel disease:
an epidemiological case-control study. Arq Gastroenterol 33(2): 74-78.
44. Rota, M.T., et al.. (199). Tobacco smoke in the development and therapy of
periodontal disease: progress and questions. Bull Group Int Rech Sci Stomatol
Odontol. 41(4): p. 116-22

66

45. Centers for Disease Control and Prevention (US); National Center for Chronic
Disease Prevention and Health Promotion (US); Office on Smoking and Health
(US) (2010). How Tobacco Smoke Causes Disease: The Biology and Behavioral
Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta
(GA): Centers for Disease Control and Prevention (US). 6, Cardiovascular
Diseases.
46. Huxley R, Woodward M (2011). Cigarette smoking as a risk factor for coronary
heart disease in women compared with men: a systematic review and metaanalysis of prospective cohort studies. Lancet;378(9799): 1297–1300.
47. Attili, A. K., Kazerooni, E. A., Gross, B. H., Flaherty, K. R., Myers, J. L., &
Martinez, F. J. (2008). Smoking-related Interstitial Lung Disease: RadiologicClinical-Pathologic
Correlation1.
RadioGraphics,
28(5),
1383-1396.
doi:10.1148/rg.285075223
48. Thorley, A. J., & Tetley, T. D. (2007). Pulmonary epithelium, cigarette smoke,
and chronic obstructive pulmonary disease. International Journal of Chronic
Obstructive Pulmonary Disease, 2(4), 409–428
49. Johannsen, A., Susin, C., & Gustafsson, A. (2013). Smoking and inflammation:
Evidence for a synergistic role in chronic disease. Periodontology 2000, 64(1),
111-126. doi:10.1111/j.1600-0757.2012.00456.x
50. Cooper,R. G. (2006). Effect of tobacco smoking on renal function. Indian J Med
Res, 124 (3): 261–268
51. Rubin, G. P., Hungin, A. P., Kelly, P. J., & Ling, J. (2000). Inflammatory bowel
disease: Epidemiology and management in an English general practice
population. Alimentary Pharmacology and Therapeutics , 14(12), 1553-1559.
doi:10.1046/j.1365-2036.2000.00886.x
52. Albandar, J. M. (2011). Underestimation of Periodontitis in NHANES Surveys.
Journal of Periodontology, 82(3), 337-341. doi:10.1902/jop.2011.100638
53. Ismail, G., Dumitriu, H. T., Dumitriu, A. S., & Ismail, F. B. (2013). Periodontal
Disease: A Covert Source of Inflammation in Chronic Kidney Disease Patients.
International Journal of Nephrology, 2013, 1-6. doi:10.1155/2013/515796
54. Gautam, D., Gupta, S., Kotwal, B., Jindal, V., Tuli, A., & Thakur, R. (2011).
Effect of cigarette smoking on the periodontal health status: A comparative, cross
sectional study. Journal of Indian Society of Periodontology , 15(4), 383.
doi:10.4103/0972-124x.92575

67

55. Eke, P. I., Dye, B. A., Wei, L., Thornton-Evans, G. O. & Genco, R. J. (2012).
Prevalence of periodontitis in adults in the United States: 2009 and 2010. Journal
of Dental Research 91,914–920.
56. Suzuki, N., Yoneda, M., & Hirofuji, T. (2013). Mixed Red-Complex Bacterial
Infection in Periodontitis. International Journal of Dentistry, 2013, 1-6.
doi:10.1155/2013/587279
57. Dewhirst, F. E., Chen, T., Izard, J., Paster, B. J., Tanner, A. C. R., Yu, W.-H.,
Wade, W. G. (2010). The Human Oral Microbiome. Journal of Bacteriology,
192(19), 5002–5017. http://doi.org/10.1128/JB.00542-10
58. Griffen, A. L., Beall, C. J., Campbell, J. H., Firestone, N. D., Kumar, P. S.,
Yang, Z. K., Leys, E. J. (2011). Distinct and complex bacterial profiles in human
periodontitis and health revealed by 16S pyrosequencing. The ISME Journal ISME
J, 6(6), 1176-1185. doi:10.1038/ismej.2011.191
59. Guthmiller, J. M., & Novak, K. F. (2002). Periodontal Diseases. Polymicrobial
Diseases, 137-152. doi:10.1128/9781555817947.ch8
60. Cekici, A., Kantarci, A., Hasturk, H., & Dyke, T. E. (2013). Inflammatory and
immune pathways in the pathogenesis of periodontal disease. Periodontology
2000, 64(1), 57-80. doi:10.1111/prd.12002
61. Dennison, D. K. & Van Dyke, T. E. (1997). The acute inflammatory response
and the role of phagocytic cells in periodontal health and disease. Periodontology
2000 14, 54–78.
62. Lee, W., Aitken, S., Sodek, J., & Mcculloch, C. A. (1995). Evidence of a direct
relationship between neutrophil collagenase activity and periodontal tissue
destruction in vivo: Role of active enzyme in human periodontitis. Journal of
Periodontal Research, 30(1), 23-33. doi:10.1111/j.1600-0765.1995.tb01249.x
63. Sreedevi, M., Ramesh, A., & Dwarakanath, C. (2012). Periodontal Status in
Smokers and Nonsmokers: A Clinical, Microbiological, and Histopathological
Study. International Journal of Dentistry, 2012, 1-10. doi:10.1155/2012/571590
64. Luzzi, L. I., Greghi, S. L., Passanezi, E., Sant'ana, A. C., Lauris, J. R., &
Cestari, T. M. (2007). Evaluation of clinical periodontal conditions in smokers and
non-smokers. Journal of Applied Oral Science, 15(6). doi:10.1590/s167877572007000600011
65. Raulin, L. A., Mcpherson, J. C., Mcquade, M. J., & Hanson, B. S. (1988). The
Effect of Nicotine on the Attachment of Human Fibroblasts to Glass and Human
Root Surfaces in Vitro. Journal of Periodontology, 59(5), 318-325.
doi:10.1902/jop.1988.59.5.318

68

66. Kenney, E. B., Kraal, J. H., Saxe, S. R., & Jones, J. (1977). The effect of
cigarette smoke on human oral polymorphonuclear leukocytes. Journal of
Periodontal Research, 12(4), 227-234. doi:10.1111/j.1600-0765.1977.tb00126.x
67. Holt, P. G. (1987). Immune and inflammatory function in cigarette smokers.
Thorax, 42(4), 241-249. doi:10.1136/thx.42.4.241
68. Pankow, W., Neumann, K., Rüschoff, J., Schröder, R., & Wichert, P. V. (1991).
Reduction in HLA-DR antigen density on alveolar macrophages of smokers. Lung,
169(1), 255-262. doi:10.1007/bf02714161
69. Mancini, N. M., Béné, M. C., Gérard, H., Chabot, F., Faure, G., Polu, J. M., &
Lesur, O. (1993). Early Effects of Short-Time Cigarette Smoking on the Human
Lung: A Study of Bronchoalveolar Lavage Fluids. Lung, 171(5), 277-291.
doi:10.1007/bf03215871
70. Palmer, R. M., et al.. (2005). "Mechanisms of action of environmental factors-tobacco smoking." J Clin Periodontol 32 Suppl 6: 180-195.
71. Graves, D. (2008). Cytokines That Promote Periodontal Tissue Destruction.
Journal of Periodontology, 79(8s), 1585-1591. doi:10.1902/jop.2008.080183s
72. Ferson, M., Edwards, A., Lind, A., Milton, G. W., & Hersey, P. (1979). Low
natural killer-cell activity and immunoglobulin levels associated with smoking in
human subjects. International Journal of Cancer, 23(5), 603-609.
doi:10.1002/ijc.2910230504
73. Hersey, P., et al.. (1983). Effects of cigarette smoking on the immune system.
Follow-up studies in normal subjects after cessation of smoking. Med J Aust 2(9):
425-429.
74. Ulloa, L. (2005). The vagus nerve and the nicotinic anti-inflammatory pathway.
Nature Reviews Drug Discovery, 4(8), 673-684. doi:10.1038/nrd1797
75. Wang, H., Yu, M., Ochani, M., Amella, C. A., Tanovic, M., Susarla, S.,
Tracey, K. J. (2002). Nicotinic acetylcholine receptor α7 subunit is an essential
regulator of inflammation. Nature, 421(6921), 384-388. doi:10.1038/nature01339
76. Borovikova, L. V., et al.. (2000). Vagus nerve stimulation attenuates the
systemic inflammatory response to endotoxin. Nature 405(6785):
77. Kherani, A. R., et al.. (2004). Macrophage inhibitor, semapimod, reduces tumor
necrosis factor-alpha in myocardium in a rat model of ischemic heart failure. J
Cardiovasc Pharmacol 44(6): 665-671.

69

78. Jonge, W. J., Zanden, E. P., The, F. O., Bijlsma, M. F., Westerloo, D. J.,
Bennink, R. J., Boeckxstaens, G. E. (2005). Stimulation of the vagus nerve
attenuates macrophage activation by activating the Jak2-STAT3 signaling
pathway. Nature Immunology, 6(8), 844-851. doi:10.1038/ni1229
79. Goutoudi, P., Diza, E., & Arvanitidou, M. (2004). Effect of periodontal therapy
on crevicular fluid interleukin-1β and interleukin-10 levels in chronic periodontitis.
Journal of Dentistry, 32(7), 511-520. doi:10.1016/j.jdent.2004.04.003
80. Petropoulos, G., Mckay, I. J., & Hughes, F. J. (2004). The association between
neutrophil numbers and interleukin-1alpha concentrations in gingival crevicular
fluid of smokers and non-smokers with periodontal disease. Journal of Clinical
Periodontology, 31(5), 390-395. doi:10.1111/j.1600-051x.2004.00489.x
81. Shirodaria, S., Smith, J., Mckay, I., Kennett, C., & Hughes, F. (2000).
Polymorphisms in the IL-1A Gene are Correlated with Levels of Interleukin-1
Protein in Gingival Crevicular Fluid of Teeth with Severe Periodontal Disease.
Journal
of
Dental
Research,
79(11),
1864-1869.
doi:10.1177/00220345000790110801
82. Scott, D., & Singer, D. (2004). Suppression of overt gingival inflammation in
tobacco smokers - clinical and mechanistic considerations. International Journal
of Dental Hygiene, 2(3), 104-110. doi:10.1111/j.1601-5037.2004.00079.x
83. Lamont, R. J., & Jenkinson, H. F. (1998). Life Below the Gum Line: Pathogenic
Mechanisms of Porphyromonas gingivalis. Microbiology and Molecular Biology
Reviews, 62(4), 1244–1263.
84. How, K. Y., Song, K. P., & Chan, K. G. (2016). Porphyromonas gingivalis: An
Overview of Periodontopathic Pathogen below the Gum Line. Frontiers in
Microbiology, 7. doi:10.3389/fmicb.2016.00053
85. Mysak, J., Podzimek, S., Sommerova, P., Lyuya-Mi, Y., Bartova, J., Janatova,
T., Duskova, J. (2014). Porphyromonas gingivalis: Major Periodontopathic
Pathogen Overview. Journal of Immunology Research, 2014, 1-8.
doi:10.1155/2014/476068
86. Grossi, S. G., Goodson, J. M., Gunsolley, J. C., Otomo-Corgel, J., Bland, P.
S., Doherty, F., & Comiskey, J. (2007). Mechanical Therapy With Adjunctive
Minocycline Microspheres Reduces Red-Complex Bacteria in Smokers. Journal of
Periodontology, 78(9), 1741-1750. doi:10.1902/jop.2007.070118
87. Bodet, C., Chandad, F., & Grenier, D. (2007). Potentiel pathogénique
de Porphyromonas gingivalis, Treponema denticola et Tannerella forsythia,
le complexe bactérien rouge associé à la parodontite. Pathologie Biologie, 55(34), 154-162. doi:10.1016/j.patbio.2006.07.045

70

88. Hajishengallis, G., & Lamont, R. (2012). Beyond the red complex and into more
complexity: The polymicrobial synergy and dysbiosis (PSD) model of periodontal
disease etiology. Molecular Oral Microbiology, 27(6), 409-419. doi:10.1111/j.20411014.2012.00663.x
89. Bello, A. D., Buonavoglia, A., Franchini, D., Valastro, C., Ventrella, G., Greco,
M. F., & Corrente, M. (2014). Periodontal disease associated with red complex
bacteria in dogs. J Small Anim Pract Journal of Small Animal Practice, 55(3), 160163. doi:10.1111/jsap.12179
90. Darveau, R. P. (2010). Periodontitis: A polymicrobial disruption of host
homeostasis.
Nature
Reviews
Microbiology,
8(7),
481-490.
doi:10.1038/nrmicro2337
91. Selke, D., Klumpp, S., Kaupp, B., & Baumann, A. (1998). Molecular Cloning of
Protein Phosphatase Type 2C Isoforms from Retinal cDNA. Protein Phosphatase
Protocols, 243-250. doi:10.1385/0-89603-468-2:243
92. Amano, A. (2010). Bacterial adhesins
periodontitis.Periodontology 2000, 52(1), 12-37.

to

host

components

in

93. Amano, A., Sharma, A., Lee, J. Y., Sojar, H. T., Raj, P. A., & Genco, R. J.
(1996). Structural domains of Porphyromonas gingivalis recombinant fimbrillin that
mediate binding to salivary proline-rich protein and statherin. Infection and
Immunity, 64(5), 1631–1637.
94. Amano, A., Shizukuishi, S., Horie, H., Kimura, S., Morisaki, I., & Hamada, S.
(1998). Binding of Porphyromonas gingivalis Fimbriae to Proline-Rich
Glycoproteins in Parotid Saliva via a Domain Shared by Major Salivary
Components. Infection and Immunity, 66(5), 2072–2077.
95. Lamont, R. J., & Jenkinson, H. F. (2000). Subgingival colonization by
Porphyromonas gingivalis. Oral Microbiology and Immunology , 15(6), 341-349.
doi:10.1034/j.1399-302x.2000. 150601.x
96. Holt, S. C., & Ebersole, J. L. (2005). Porphyromonas gingivalis, Treponema
denticola, and Tannerella forsythia: The 'red complex', a prototype polybacterial
pathogenic consortium in periodontitis. Periodontology 2000, 38(1), 72-122.
doi:10.1111/j.1600-0757.2005. 00113.x
97. Lamont, R. J., Park, Y., Costerton, J. W., Cook, G. S., Demuth, D. R., & ElSabaeny, A. (2002). Role of the Streptococcus gordonii SspB protein in the
development of Porphyromonas gingivalis biofilms on streptococcal substrates.
Microbiology, 148(6), 1627-1636. doi:10.1099/00221287-148-6-1627

71

98. Sojar, H. T., & Genco, R. J. (2005). Identification of glyceraldehyde-3phosphate dehydrogenase of epithelial cells as a second molecule that binds to
Porphyromonas gingivalis fimbriae. FEMS Immunology & Medical Microbiology,
45(1), 25-30. doi: 10.1016/j.femsim.2005.01.006
99. Yamasaki, Y., Nomura, R., Nakano, K., Inaba, H., Kuboniwa, M., Hirai, N., . . .
Asai, F. (2012). Distribution and molecular characterization of Porphyromonas
gulae carrying a new fimA genotype. Veterinary Microbiology, 161(1-2), 196-205.
doi: 10.1016/j.vetmic.2012.07.026
100. Fujiwara, T., Morishima, S., Takahashi, I., & Hamada, S. (1993). Molecular
Cloning and Sequencing of the Fimbrilin Gene of Porphyromonas gingivalis Strains
and Characterization of Recombinant Proteins. Biochemical and Biophysical
Research Communications, 197(1), 241-247. doi:10.1006/bbrc.1993.2467
101. Amano, A., Nakagawa, I., Okahashi, N., & Hamada, N. (2004). Variations of
Porphyromonas gingivalis fimbriae in relation to microbial pathogenesis. Journal
of Periodontal Research, 39(2), 136-142. doi:10.1111/j.1600-0765.2004. 00719.x
102. Neiders, M. E., Chen, P. B., Suido, H., Reynolds, H. S., Zambon, J. J.,
Shlossman, M., & Genco, R. J. (1989). Heterogeneity of virulence among strains
of Bacteroides gingivalis. Journal of Periodontal Research, 24(3), 192-198.
doi:10.1111/j.1600-0765. 1989.tb02005.x
103. Genco, C. A., Dyke, T. V., & Amar, S. (1998). Animal models for
Porphyromonas gingivalis-mediated periodontal disease. Trends in Microbiology,
6(11), 444-449. doi:10.1016/s0966-842x(98)01363-8
104. Nakagawa, I. (2002). Functional Differences among FimA Variants of
Porphyromonas gingivalis and Their Effects on Adhesion to and Invasion of
Human Epithelial Cells. Infection and Immunity, 70(1), 277-285.
doi:10.1128/iai.70.1.277-285.2002
105. Hajishengallis, G., Tapping, R. I., Harokopakis, E., Nishiyama, S., Ratti, P.,
Schifferle, R. E., . . . Yoshimura, F. (2006). Differential interactions of fimbriae and
lipopolysaccharide from Porphyromonas gingivalis with the Toll-like receptor 2centred pattern recognition apparatus. Cellular Microbiology, 8(10), 1557-1570.
doi:10.1111/j.1462-5822.2006.00730.x
106. Asai, Y., Ohyama, Y., Gen, K., & Ogawa, T. (2001). Bacterial Fimbriae and
Their Peptides Activate Human Gingival Epithelial Cells through Toll-Like Receptor
2. Infection and Immunity, 69(12), 7387-7395. doi:10.1128/iai.69.12.73877395.2001
107. Davey, M., Liu, X., Ukai, T., Jain, V., Gudino, C., Gibson, F. C., . . . Genco,
C. A. (2008). Bacterial Fimbriae Stimulate Proinflammatory Activation in the

72

Endothelium through Distinct TLRs. The Journal of Immunology, 180(4), 21872195. doi:10.4049/jimmunol.180.4.2187
108. Hamada, N., Sojar, H. T., Cho, M. I., & Genco, R. J. (1996). Isolation and
characterization of a minor fimbria from Porphyromonas gingivalis. Infection and
Immunity, 64(11), 4788–4794.
109. Kuboniwa, M., & Lamont, R. J. (2010). Subgingival biofilm formation.
Periodontology 2000, 52(1), 38-52. doi:10.1111/j.1600-0757.2009.00311.x
110. Hiramine, H., Watanabe, K., Hamada, N., & Umemoto, T. (2003).
Porphyromonas gingivalis 67-kDa fimbriae induced cytokine production and
osteoclast differentiation utilizing TLR2. FEMS Microbiology Letters, 229(1), 4955. doi:10.1016/s0378-1097(03)00788-2
111. Hamada, N., Watanabe, K., Arai, M., Hiramine, H., & Umemoto, T. (2002).
Cytokine production induced by a 67-kDa fimbrial protein from Porphyromonas
gingivalis. Oral Microbiology and Immunology, 17(3), 197-200. doi:10.1034/j.1399302x.2002.170311.x
112. Zaragoza, O., Rodrigues, M. L., Jesus, M. D., Frases, S., Dadachova, E., &
Casadevall, A. (2009). Chapter 4 The Capsule of the Fungal Pathogen
Cryptococcus neoformans. Advances in Applied Microbiology, 133-216.
doi:10.1016/s0065-2164(09)01204-0
113. Deangelis, P. L. (2002). Evolution of glycosaminoglycans and their
glycosyltransferases: Implications for the extracellular matrices of animals and the
capsules of pathogenic bacteria. The Anatomical Record, 268(3), 317-326.
doi:10.1002/ar.10163
114. Sundqvist, G., Figdor, D., Hänström, L., Sörlin, S., & Sandström, G. (1991).
Phagocytosis and virulence of different strains of Porphyromonas gingivalis. Eur J
Oral Sci European Journal of Oral Sciences, 99(2), 117-129. doi:10.1111/j.16000722.1991.tb01874.x
115. Slaney, J. M., Gallagher, A., Aduse-Opoku, J., Pell, K., & Curtis, M. A. (2006).
Mechanisms of Resistance of Porphyromonas gingivalis to Killing by Serum
Complement. Infection and Immunity, 74(9), 5352-5361. doi:10.1128/iai.00304-06
116. Ebersole, J., Kesavaln, L., Schneider, S., Machen, R., & Holt, S. (2008).
Comparative virulence of periodontopathogens in a mouse abscess model. Oral
Diseases, 1(3), 115-128. doi:10.1111/j.1601-0825.1995.tb00174.x
117. Laine, M. L., & Winkelhoff, A. J. (1998). Virulence of six capsular serotypes
of Porphyromonas gingivalis in a mouse model. Oral Microbiology and
Immunology, 13(5), 322-325. doi:10.1111/j.1399-302x.1998.tb00714.x

73

118. Singh, A., Wyant, T., Anaya-Bergman, C., Aduse-Opoku, J., Brunner, J.,
Laine, M. L., . . . Lewis, J. P. (2011). The Capsule of Porphyromonas gingivalis
Leads to a Reduction in the Host Inflammatory Response, Evasion of
Phagocytosis, and Increase in Virulence. Infection and Immunity, 79(11), 45334542. doi:10.1128/iai.05016-11
119. Katz, J., Ward, D. C., & Michalek, S. M. (1996). Effect of host responses on
the pathogenicity of strains of Porphyromonas gingivalis. Oral Microbiology and
Immunology, 11(5), 309-318. doi:10.1111/j.1399-302x.1996.tb00187.x
120. Vernal, R., León, R., Silva, A., Winkelhoff, A. J., Garcia-Sanz, J. A., & Sanz,
M. (2009). Differential cytokine expression by human dendritic cells in response to
different Porphyromonas gingivalis capsular serotypes. Journal of Clinical
Periodontology, 36(10), 823-829. doi:10.1111/j.1600-051x.2009.01462.x
121. D'empaire, G., Baer, M. T., & Gibson, F. C. (2006). The K1 Serotype Capsular
Polysaccharide of Porphyromonas gingivalis Elicits Chemokine Production from
Murine Macrophages That Facilitates Cell Migration. Infection and Immunity,
74(11), 6236-6243. doi:10.1128/iai.00519-06
122. Igboin, C. O., Tordoff, K. P., Moeschberger, M. L., Griffen, A. L., & Leys, E. J.
(2010). Porphyromonas gingivalis-Host Interactions in a Drosophila melanogaster
Model. Infection and Immunity, 79(1), 449-458. doi:10.1128/iai.00785-10
123. Nikaido, H. (2003). Molecular Basis of Bacterial Outer Membrane
Permeability Revisited. Microbiology and Molecular Biology Reviews, 67(4), 593656. doi:10.1128/mmbr.67.4.593-656.2003
124. Wang, X., & Quinn, P. J. (2010). Lipopolysaccharide: Biosynthetic pathway
and structure modification. Progress in Lipid Research, 49(2), 97-107. doi:
10.1016/j.plipres.2009.06.002
125. Erridge, C., Stewart, J., Bennett-Guerrero, E., Mcintosh, T. J., & Poxton, I. R.
(2002). The biological activity of a liposomal complete core lipopolysaccharide
vaccine.
Journal
of
Endotoxin
Research,
8(1),
39-46.
doi:10.1177/09680519020080010401
126. Lerouge, I., & Vanderleyden, J. (2002). O-antigen structural variation:
Mechanisms and possible roles in animal/plant–microbe interactions. FEMS
Microbiology Reviews, 26(1), 17-47. doi:10.1111/j.1574-6976. 2002.tb00597.x
127. Jain, S., & Darveau, R. P. (2010). Contribution of Porphyromonas gingivalis
lipopolysaccharide to periodontitis. Periodontology 2000, 54(1), 53-70.
doi:10.1111/j.1600-0757.2009. 00333.x

74

128. Janeway, C. A., Travers, P., Walport, M., et al. (2001). Immunobiology: The
Immune System in Health and Disease. 5th edition. New York: Garland Science.
129. Herath, T., Wang, Y., Seneviratne, C., Darveau, R., Wang, C., & Jin, L.
(2011). Heterogeneous LPS of Porphyromonas gingivalis differentially modulate
the innate immune response of human gingiva. BMC Proc BMC Proceedings,
5(Suppl 1). doi:10.1186/1753-6561-5-s1-p86
130. Kato, H., Taguchi, Y., Tominaga, K., Umeda, M., & Tanaka, A. (2014).
Porphyromonas gingivalis LPS inhibits osteoblastic differentiation and promotes
pro-inflammatory cytokine production in human periodontal ligament stem cells.
Archives of Oral Biology, 59(2), 167-175. doi:10.1016/j.archoralbio.2013.11.008
131. Kumada H, Haishima Y, Watanabe K, Hasegawa C, Tsuchiya T, Tanamoto
K, Umemoto T. (2008) Biological properties of the native and synthetic lipid A of
Porphyromonas gingivalis lipopolysaccharide. Oral Microbiology and Immunology,
23(1), 60-69. doi: 10.1111/j.1399-302X.2007.00392.x.
132. Kocgozlu, L., Elkaim, R., Tenenbaum, H., and Werner, S. (2009). Variable
cell responses to P. gingivalis lipopolysaccharide. J Dent Res, 88(8), 741-742.
133. Gokyu, M., Kobayashi, H., Nanbara, H., Sudo, T., Ikeda, Y., Suda, T., & Izumi,
Y. (2014). Thrombospondin-1 Production Is Enhanced by Porphyromonas
gingivalis Lipopolysaccharide in THP-1 Cells. PLoS ONE, 9(12).
doi:10.1371/journal.pone.0115107
134. Darveau, R. P., Pham, T. T., Lemley, K., Reife, R. A., Bainbridge, B. W.,
Coats, S. R., Hajjar, A. M. (2004). Porphyromonas gingivalis Lipopolysaccharide
Contains Multiple Lipid A Species That Functionally Interact with Both Toll-Like
Receptors 2 and 4. Infection and Immunity, 72(9), 5041-5051.
doi:10.1128/iai.72.9.5041-5051.2004
135. Kumada, H., Haishima, Y., Umemoto, T., & Tanamoto, K. (1995). Structural
study on the free lipid A isolated from lipopolysaccharide of Porphyromonas
gingivalis. Journal of Bacteriology, 177(8), 2098–2106.
136. Potempa, J., Banbula, A., & Travis, J. (2000). Role of bacterial proteinases in
matrix destruction and modulation of host responses. Periodontology 2000, 24(1),
153-192. doi:10.1034/j.1600-0757.2000.2240108.x
137. Holt, S. C., et al.. (1999). Virulence factors of Porphyromonas gingivalis.
Periodontology 2000 20(1): 168-238
138. Imamura, T., Travis, J., & Potempa, J. (2003). The Biphasic Virulence
Activities of Gingipains: Activation and Inactivation of Host Proteins. Current
Protein & Peptide Science CPPS, 4(6), 443-450. doi:10.2174/1389203033487027

75

139. Curtis, M., Aduse-Opoku, J., & Rangarajan, M. (2001). Cysteine Proteases of
Porphyromonas Gingivalis. Critical Reviews in Oral Biology & Medicine, 12(3),
192-216. doi:10.1177/10454411010120030101
140. Grenier, D., & La, V. D. (2011). Proteases of Porphyromonas gingivalis as
Important Virulence Factors in Periodontal Disease and Potential Targets for PlantDerived Compounds: A Review Article. Current Drug Targets CDT, 12(3), 322331. doi:10.2174/138945011794815310
141. Kumagai, Y., Yagishita, H., Yajima, A., Okamoto, T., & Konishi, K. (2005).
Molecular Mechanism for Connective Tissue Destruction by Dipeptidyl
Aminopeptidase IV Produced by the Periodontal Pathogen Porphyromonas
gingivalis. Infection and Immunity, 73(5), 2655-2664. doi:10.1128/iai.73.5.26552664.2005
142. Aruni, A. W., Roy, F., & Fletcher, H. M. (2011). Filifactor alocis Has Virulence
Attributes That Can Enhance Its Persistence under Oxidative Stress Conditions
and Mediate Invasion of Epithelial Cells by Porphyromonas gingivalis. Infection
and Immunity, 79(10), 3872-3886. doi:10.1128/iai.05631-11
143. Cato, E. P., Moore, L. V., & Moore, W. E. (1985). Fusobacterium alocis sp.
nov. and Fusobacterium sulci sp. nov. from the Human Gingival Sulcus.
International
Journal
of
Systematic
Bacteriology,
35(4),
475-477.
doi:10.1099/00207713-35-4-475
144. Jalava, J., & Eerola, E. (1999). Phylogenetic analysis of Fusobacterium alocis
and Fusobacterium sulci based on 16S rRNA gene sequences: Proposal of
Filifactor alocis (Cato, Moore and Moore) comb. nov. and Eubacterium sulci (Cato,
Moore and Moore) comb. nov. International Journal of Systematic Bacteriology,
49(4), 1375-1379. doi:10.1099/00207713-49-4-1375
145. Wang, Q., Wright, C. J., Dingming, H., Uriarte, S. M., & Lamont, R. J. (2013).
Oral Community Interactions of Filifactor alocis In Vitro. PLoS ONE, 8(10).
doi:10.1371/journal.pone.0076271
146. Kumar, P., Griffen, A., Barton, J., Paster, B., Moeschberger, M., & Leys, E.
(2003). New Bacterial Species Associated with Chronic Periodontitis. Journal of
Dental Research, 82(5), 338-344. doi:10.1177/154405910308200503
147. Wade, W. G. (2011). Has the use of molecular methods for the
characterization of the human oral microbiome changed our understanding of the
role of bacteria in the pathogenesis of periodontal disease? Journal of Clinical
Periodontology, 38, 7-16. doi:10.1111/j.1600-051x.2010.01679.x

76

148. Uematsu, H., Sato, N., Hossain, M., Ikeda, T., & Hoshino, E. (2003).
Degradation of arginine and other amino acids by butyrate-producing
asaccharolytic anaerobic Gram-positive rods in periodontal pockets. Archives of
Oral Biology, 48(6), 423-429. doi:10.1016/s0003-9969(03)00031-1
149. Aruni, A. W., Zhang, K., Dou, Y., & Fletcher, H. (2014). Proteome Analysis of
Coinfection of Epithelial Cells with Filifactor alocis and Porphyromonas gingivalis
Shows Modulation of Pathogen and Host Regulatory Pathways. Infection and
Immunity, 82(8), 3261-3274. doi:10.1128/iai.01727-14
150. Yilmaz, O. (2008). The chronicles of Porphyromonas gingivalis: The
microbium, the human oral epithelium and their interplay. Microbiology, 154(10),
2897-2903. doi:10.1099/mic.0.2008/021220-0
151. Kagnoff, M. F. and L. Eckmann (1997). Epithelial cells as sensors for
microbial infection. J Clin Invest 100(1): 6-10
152. Attstro ̈m, R., and J. Egelberg (1970). Emigration of blood neutrophils and
monocytes into the gingival crevices. J. Periodontal Res. 5:48–55
153. Page, R. C., and H. E. Schroeder (1976). Pathogenesis of inflammatory
periodontal disease. A summary of current work. Lab. Invest. 34:235–249.
154. Moffatt, C., Whitmore, S., Griffen, A., Leys, E., & Lamont, R. (2011). Filifactor
alocis interactions with gingival epithelial cells. Molecular Oral Microbiology, 26(6),
365-373. doi:10.1111/j.2041-1014.2011.00624.x
155. Preshaw, P. M., & Taylor, J. J. (2011). How has research into cytokine
interactions and their role in driving immune responses impacted our
understanding of periodontitis? Journal of Clinical Periodontology, 38, 6084.doi:10.1111/j.1600-051x.2010.01671.x
156. Meng, J., Fang, B., Liao, Y., Chresta, C. M., Smith, P. D., & Roth, J. A. (2010).
Apoptosis Induction by MEK Inhibition in Human Lung Cancer Cells Is Mediated
by Bim. PLoS ONE, 5(9). doi:10.1371/journal.pone.0013026
157. Waddington, R. J., et al.. (2000). "Reactive oxygen species: a potential role
in the pathogenesis of periodontal diseases." Oral Dis 6(3): 138-151.
158. Baelum, V., & Lopez, R. (2004). Periodontal epidemiology: Towards social
science or molecular biology? Community Dentistry and Oral Epidemiology, 32(4),
239-249. doi:10.1111/j.1600-0528.2004.00159.x
159. Katsuragi, H., Ohtake, M., Kurasawa, I., & Saito, K. (2003). Intracellular
production and extracellular release of oxygen radicals by PMNs and oxidative

77

stress on PMNs during phagocytosis of periodontopathic bacteria. Odontology,
91(1), 13-18. doi:10.1007/s10266-003-0022-1
160. Brigham, C., Caughlan, R., Gallegos, R., Dallas, M. B., Godoy, V. G., &
Malamy, M. H. (2009). Sialic Acid (N-Acetyl Neuraminic Acid) Utilization by
Bacteroides fragilis Requires a Novel N-Acetyl Mannosamine Epimerase. Journal
of Bacteriology, 191(11), 3629-3638. doi:10.1128/jb.00811-08
161. D'elios, M. M., Amedei, A., Cappon, A., Prete, G. D., & Bernard, M. D. (2007).
The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune
modulating agent. FEMS Immunology & Medical Microbiology, 50(2), 157-164.
doi:10.1111/j.1574-695x.2007.00258.x
162. Cooksley, C. (2003). NapA protects Helicobacter pylori from oxidative stress
damage, and its production is influenced by the ferric uptake regulator. Journal of
Medical Microbiology, 52(6), 461-469. doi:10.1099/jmm.0.05070-0
163. Serrano-Luna, J., Piña-Vázquez, C., Reyes-López, M., Ortiz-Estrada, G., &
Garza, M. D. (2013). Proteases from Entamoeba spp. and Pathogenic Free-Living
Amoebae as Virulence Factors. Journal of Tropical Medicine, 2013, 1-32.
doi:10.1155/2013/890603
164. Guo, L. H., Wang, H. L., Liu, X. D., & Duan, J. (2008). Identification of protein
differences between two clinical isolates of Streptococcus mutans by proteomic
analysis. Oral Microbiology and Immunology, 23(2), 105-111. doi:10.1111/j.1399302x.2007.00394.x
165. Lamont, R., Meila, M., Xia, Q., & Hackett, M. (2006). Mass SpectrometryBased Proteomics and its Application to Studies of Porphyromonas gingivalis
Invasion and Pathogenicity. IDDT Infectious Disorders - Drug Targets, 6(3), 311325. doi:10.2174/187152606778249935
166. Al-Haroni, M., Skaug, N., Bakken, V., & Cash, P. (2007). Proteomic analysis
of ampicillin-resistant oral Fusobacterium nucleatum. Oral Microbiology and
Immunology, 23(1), 36-42. doi:10.1111/j.1399-302x.2007.00387.x
167. Aruni, A. W., Roy, F., Sandberg, L., & Fletcher, H. M. (2012). Proteome
variation among Filifactor alocis strains. Proteomics, 12(22), 3343-3364.
doi:10.1002/pmic.201200211
168. Zhang, Y., Whiteley, M., Kreth, J., Lei, Y., Khammanivong, A., Evavold, J.
N., Herzberg, M. C. (2009). The two-component system BfrAB regulates
expression of ABC transporters in Streptococcus gordonii and Streptococcus
sanguinis. Microbiology, 155(1), 165-173. doi:10.1099/mic.0.023168-0

78

169. Doroshchuk, N. A., Gelfand, M. S., & Rodionov, D. A. (2006). Regulation of
nitrogen metabolism in gram-positive bacteria. Molecular Biology, 40(5), 829-836.
doi:10.1134/s0026893306050190
170. Sandkvist, M. (2001). Type II Secretion and Pathogenesis. Infection and
Immunity, 69(6), 3523-3535. doi:10.1128/iai.69.6.3523-3535.2001
171. Reizer, J., Reizer, A., & Saier, M. H. (1992). The putative Na /H antiporter
(NapA) of Enterococcus hirae is homologous to the putative K /H antiporter (KefC)
of Escherichia coli. FEMS Microbiology Letters, 94(1-2), 161-163.
doi:10.1111/j.1574-6968.1992.tb05307.x
172. Henderson, B., Nair, S., Pallas, J., & Williams, M. A. (2011). Fibronectin: A
multidomain host adhesin targeted by bacterial fibronectin-binding proteins. FEMS
Microbiology Reviews, 35(1), 147-200. doi:10.1111/j.1574-6976.2010.00243.x
173. Henderson, B., & Martin, A. (2011). Bacterial Virulence in the Moonlight:
Multitasking Bacterial Moonlighting Proteins Are Virulence Determinants in
Infectious
Disease.
Infection
and
Immunity,
79(9),
3476-3491.
doi:10.1128/iai.00179-11
174. Huberts, D. H., & Klei, I. J. (2010). Moonlighting proteins: An intriguing mode
of multitasking. Biochimica Et Biophysica Acta (BBA) - Molecular Cell Research,
1803(4), 520-525. doi:10.1016/j.bbamcr.2010.01.022
175. Charon, N. W., Goldstein, S. F., Block, S. M., Curci, K., Ruby, J. D., Kreiling,
J. A., & Limberger, R. J. (1992). Morphology and dynamics of protruding spirochete
periplasmic flagella. Journal of Bacteriology, 174(3), 832–840.
176. Kolenbrander, P. E., Andersen, R. N., Blehert, D. S., Egland, P. G., Foster, J.
S., & Palmer, R. J. (2002). Communication among Oral Bacteria. Microbiology and
Molecular Biology Reviews, 66(3), 486-505. doi:10.1128/mmbr.66.3.486505.2002
177. Sela M (2001). Role of Treponema denticola in periodontal diseases. Crit Rev
Oral Biol Med 12:399-413.
178. Holt, S. C., & Ebersole, J. L. (2005). Porphyromonas gingivalis, Treponema
denticola, and Tannerella forsythia: The 'red complex', a prototype polybacterial
pathogenic consortium in periodontitis. Periodontology 2000, 38(1), 72-122.
doi:10.1111/j.1600-0757.2005.00113.x
179. Foschi, F., Izard, J., Sasaki, H., Sambri, V., Prati, C., Muller, R., & Stashenko,
P. (2006). Treponema denticola in Disseminating Endodontic Infections. Journal
of Dental Research, 85(8), 761-765. doi:10.1177/154405910608500814

79

180. Robertson, D., & Smith, A. J. (2009). The microbiology of the acute dental
abscess.
Journal
of
Medical
Microbiology,
58(2),
155-162.
doi:10.1099/jmm.0.003517-0
181. Dashper, S. G., Seers, C. A., Tan, K. H., & Reynolds, E. C. (2010). Virulence
Factors of the Oral Spirochete Treponema denticola. Journal of Dental Research,
90(6), 691-703. doi:10.1177/0022034510385242
182. Kaplan, C. W., Lux, R., Haake, S. K., & Shi, W. (2009). The Fusobacterium
nucleatum outer membrane protein RadD is an arginine-inhibitable adhesin
required for inter-species adherence and the structured architecture of
multispecies biofilm. Molecular Microbiology, 71(1), 35-47. doi:10.1111/j.13652958.2008.06503.x
183. Kolenbrander, P. E., Parrish, K. D., Andersen, R. N., & Greenberg, E. P.
(1995). Intergeneric coaggregation of oral Treponema spp. with Fusobacterium
spp. and intrageneric coaggregation among Fusobacterium spp. Infection and
Immunity, 63(12), 4584–4588.
184. Yao, E. S., Lament, R. J., Leu, S. P., & Weinberg, A. (1996). Interbacterial
binding among strains of pathogenic and commensal oral bacterial species. Oral
Microbiology
and
Immunology,
11(1),
35-41.
doi:10.1111/j.1399302x.1996.tb00334.x
185. Hashimoto, M., Ogawa, S., Asai, Y., Takai, Y., & Ogawa, T. (2003). Binding
of Porphyromonas gingivalis fimbriae to Treponema denticola dentilisin. FEMS
Microbiology Letters, 226(2), 267-271. doi:10.1016/s0378-1097(03)00615-3
186. Sharma, A., Sojar, H. T., Glurich, I., Honma, K., Kuramitsu, H. K., & Genco,
R. J. (1998). Cloning, Expression, and Sequencing of a Cell Surface Antigen
Containing a Leucine-Rich Repeat Motif from Bacteroides forsythus ATCC 43037.
Infection and Immunity, 66(12), 5703–5710.
187. Sharma, A., Inagaki, S., Honma, K., Sfintescu, C., Baker, P., & Evans, R.
(2005). Tannerella forsythia-induced Alveolar Bone Loss in Mice Involves Leucinerich-repeat BspA Protein. Journal of Dental Research, 84(5), 462-467.
doi:10.1177/154405910508400512
188. Capestany, C. A., Kuboniwa, M., Jung, I., Park, Y., Tribble, G. D., & Lamont,
R. J. (2006). Role of the Porphyromonas gingivalis InlJ Protein in Homotypic and
Heterotypic Biofilm Development. Infection and Immunity, 74(5), 3002-3005.
doi:10.1128/iai.74.5.3002-3005.2006
189. Inagaki, S., Onishi, S., Kuramitsu, H. K., & Sharma, A. (2006).
Porphyromonas gingivalis Vesicles Enhance Attachment, and the Leucine-Rich
Repeat BspA Protein Is Required for Invasion of Epithelial Cells by "Tannerella
forsythia" Infection and Immunity, 74(9), 5023-5028. doi:10.1128/iai.00062-06

80

190. Dashper, S. G., Ang, C., Veith, P. D., Mitchell, H. L., Lo, A. W., Seers, C. A.,
. . . Reynolds, E. C. (2008). Response of Porphyromonas gingivalis to Heme
Limitation in Continuous Culture. J. Bacteriol., 191(3), 1044-1055.
doi:10.1128/jb.01270-08
191. Chi, B., Qi, M., & Kuramitsu, H. K. (2003). Role of dentilisin in Treponema
denticola epithelial cell layer penetration. Research in Microbiology, 154(9), 637643. doi:10.1016/j.resmic.2003.08.001
192. Miyamoto, M., Ishihara, K., & Okuda, K. (2006). The Treponema denticola
Surface Protease Dentilisin Degrades Interleukin-1 (IL-1), IL-6, and Tumor
Necrosis Factor Alpha. Infection and Immunity, 74(4), 2462-2467.
doi:10.1128/iai.74.4.2462-2467.2006
193. Okuda, T., Kimizuka, R., Miyamoto, M., Kato, T., Yamada, S., Okuda, K., &
Ishihara, K. (2007). Treponema denticola induces interleukin-8 and macrophage
chemoattractant protein 1 production in human umbilical vein epithelial cells.
Microbes and Infection, 9(7), 907-913. doi:10.1016/j.micinf.2007.03.009
194. Fenno, J., & Mcbride, B. C. (1998). Virulence Factors of Oral Treponemes.
Anaerobe, 4(1), 1-17. doi:10.1006/anae.1997.0131
195. Ellen, R. P. (2006). Virulence determinants of oral Treponemes. In:
Pathogenic Treponema: molecular and cellular biology. Radolf JD, Lukehart SA,
editors. Wymondham, Norfolk, UK: Caister Academic Press, pp. 357-386.
196. Capone, R., Wang, H. T., Ning, Y., Sweier, D. G., Lopatin, D. E., & Fenno, J.
C. (2008). Human serum antibodies recognize Treponema denticola Msp and PrtP
protease complex proteins. Oral Microbiol Immunol, 23(2), 165-169.
doi:10.1111/j.1399-302x.2007.00404.x
197. Silva, A. P., Lee, W., Bajenova, E., Mcculloch, C. A., & Ellen, R. P. (2004).
The major outer sheath protein of Treponema denticola inhibits the binding step of
collagen phagocytosis in fibroblasts. Cellular Microbiology, 6(5), 485-498.
doi:10.1111/j.1462-5822.2004.00377.x
198. Amin, M., Grove, D. A., Kapus, A., Glogauer, M., & Ellen, R. P. (2007). An
actin-stabilizing peptide conjugate deduced from the major outer sheath protein of
the bacterium Treponema denticola. Cell Motility and the Cytoskeleton, 64(9), 662674. doi:10.1002/cm.20213
199. Thomas, B. P., Sun, C. X., Bajenova, E., Ellen, R. P., & Glogauer, M. (2006).
Modulation of Human Neutrophil Functions In Vitro by Treponema denticola Major
Outer Sheath Protein. Infection and Immunity, 74(3), 1954-1957.
doi:10.1128/iai.74.3.1954-1957.2006

81

200. Magalhães, M. A., Sun, C. X., Glogauer, M., & Ellen, R. P. (2007). The major
outer sheath protein of Treponema denticola selectively inhibits Rac1 activation in
murine neutrophils. Cellular Microbiology, 10(2). doi:10.1111/j.14625822.2007.01045.x
201. Setubal, J. C. (2006). Lipoprotein computational prediction in spirochaetal
genomes. Microbiology, 152(1), 113-121. doi:10.1099/mic.0.28317-0
202. Mcdowell, J. V., Frederick, J., Stamm, L., & Marconi, R. T. (2006).
Identification of the Gene Encoding the FhbB Protein of Treponema denticola, a
Highly Unique Factor H-Like Protein 1 Binding Protein. Infection and Immunity,
75(2), 1050-1054. doi:10.1128/iai.01458-06
203. Mcdowell, J. V., Huang, B., Fenno, J. C., & Marconi, R. T. (2009). Analysis of
a Unique Interaction between the Complement Regulatory Protein Factor H and
the Periodontal Pathogen Treponema denticola. Infection and Immunity, 77(4),
1417-1425. doi:10.1128/iai.01544-08
204. Wensink, J., & Witholt, B. (1981). Outer-Membrane Vesicles Released by
Normally Growing Escherichia coli Contain Very Little Lipoprotein. European
Journal
of
Biochemistry,
116(2),
331-335.
doi:10.1111/j.14321033.1981.tb05338.x
205. Wai, S. N., Lindmark, B., Söderblom, T., Takade, A., Westermark, M.,
Oscarsson, J., . . . Uhlin, B. E. (2003). Vesicle-Mediated Export and Assembly of
Pore-Forming Oligomers of the Enterobacterial ClyA Cytotoxin. Cell, 115(1), 2535. doi:10.1016/s0092-8674(03)00754-2
206. Kato, S., Kowashi, Y., & Demuth, D. R. (2002). Outer membrane-like vesicles
secreted by Actinobacillus actinomycetemcomitans are enriched in leukotoxin.
Microbial Pathogenesis, 32(1), 1-13. doi:10.1006/mpat.2001.0474
207. Kuehn, M. J. (2005). Bacterial outer membrane vesicles and the hostpathogen interaction. Genes & Development, 19(22), 2645-2655.
doi:10.1101/gad.1299905
208. Cimasoni, G., & Mcbride, B. (1987). Adherence of Treponema denticola to
Modified Hydroxyapatite. Journal of Dental Research, 66(12), 1727-1729.
doi:10.1177/00220345870660120601
209. Cockayne, A., Sanger, R., Ivic, A., Strugnell, R. A., Macdougall, J. H., Russell,
R. R., & Penn, C. W. (1989). Antigenic and Structural Analysis of Treponema
denticola. Microbiology, 135(12), 3209-3218. doi:10.1099/00221287-135-12-3209

82

210. Chi, B., Qi, M., & Kuramitsu, H. K. (2003). Role of dentilisin in Treponema
denticola epithelial cell layer penetration. Research in Microbiology, 154(9), 637643. doi:10.1016/j.resmic.2003.08.001
211. Cardenas, V. M., & Graham, D. Y. (2005). Smoking and Helicobacter pylori
Infection in a Sample of U.S. Adults. Epidemiology, 16(4), 586-590.
doi:10.1097/01.ede.0000165365.52904.4a
212. Zambon, J., Grossi, S., Machtei, E., Ho, A., Dunford, R., & Genco, R. (1996).
Cigarette Smoking Increases the Risk for Subgingival Infection With Periodontal
Pathogens*.
Journal
of
Periodontology,
67(10s),
1050-1054.
doi:10.1902/jop.1996.67.10s.1050
213. Haffajee, A. D., & Socransky, S. S. (2001). Relationship of cigarette smoking
to the subgingival microbiota. Journal of Clinical Periodontology, 28(5), 377-388.
doi:10.1034/j.1600-051x.2001.028005377.x
214. Kamma, J. J., Nakou, M., & Baehni, P. C. (1999). Clinical and microbiological
characteristics of smokers with early onset periodontitis. Journal of Periodontal
Research, 34(1), 25-33. doi:10.1111/j.1600-0765.1999.tb02218.x
216. Eggert, F., Mcleod, M. H., & Flowerdew, G. (2001). Effects of Smoking and
Treatment Status on Periodontal Bacteria: Evidence That Smoking Influences
Control of Periodontal Bacteria at the Mucosal Surface of the Gingival Crevice.
Journal of Periodontology, 72(9), 1210-1220. doi:10.1902/jop.2000.72.9.1210
216. Umeda, M., Chen, C., Bakker, I., Contreras, A., Morrison, J., & Slots, J.
(1998). Risk Indicators for Harboring Periodontal Pathogens. Journal of
Periodontology, 69(10), 1111-1118. doi:10.1902/jop.1998.69.10.1111
217. Winkelhoff, A. V., Bosch-Tijhof, C., Winkel, E., & Reijden, W. V. (2001).
Smoking Affects the Subgingival Microflora in Periodontitis. Journal of
Periodontology, 72(5), 666-671. doi:10.1902/jop.2001.72.5.666
218. Shiloah, J., Patters, M. R., & Waring, M. B. (2000). The Prevalence of
Pathogenic Periodontal Microflora in Healthy Young Adult Smokers. Journal of
Periodontology, 71(4), 562-567. doi:10.1902/jop.2000.71.4.562
219. Socransky, S. S., & Haffajee, A. D. (2005). Periodontal microbial ecology.
Periodontol 2000, 38(1), 135-187. doi:10.1111/j.1600-0757.2005.00107.x
220. Bizzarro, S., Loos, B. G., Laine, M. L., Crielaard, W., & Zaura, E. (2013).
Subgingival microbiome in smokers and non-smokers in periodontitis: An
exploratory study using traditional targeted techniques and a next-generation
sequencing. J Clin Periodontol, 40(5), 483-492. doi:10.1111/jcpe.12087

83

221. Camelo-Castillo, A. J., Mira, A., Pico, A., Nibali, L., Henderson, B., Donos, N.,
& Tomã¡s, I. (2015). Subgingival microbiota in health compared to periodontitis
and the influence of smoking. Front. Microbiol, 6. doi:10.3389/fmicb.2015.00119
222. Bagaitkar, J., Williams, L. R., Renaud, D. E., Bemakanakere, M. R., Martin,
M., Scott, D. A., & Demuth, D. R. (2009). Tobacco-induced alterations to
Porphyromonas gingivalis -host interactions. Environmental Microbiology, 11(5),
1242-1253. doi:10.1111/j.1462-2920.2008.01852.x
223. Chan, Y., Ma, A. P., Lacap-Bugler, D. C., Huo, Y., Leung, W. K., Leung, F.
C., & Watt, R. M. (2014). Complete Genome Sequence for Treponema sp. OMZ
838 (ATCC 700772, DSM 16789), Isolated from a Necrotizing Ulcerative Gingivitis
Lesion. Genome Announcements, 2(6). doi:10.1128/genomea.01333-14
224. Nuca C., Amariei C., Badea V., Zaharia A., Bucur L., Arendt C. (2012).
Salivary cotinine - biomarker of tobacco consumption in the assessment of passive
smoking prevalence. Farmacia. 60(5):662-674.
225. Wingrove, J. A., et al.. (1992). Activation of complement components C3 and
C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides)
gingivalis. J Biol Chem 267(26): 18902-18907
226. Popadiak, K., Potempa, J., Riesbeck, K., & Blom, A. M. (2007). Biphasic
Effect of Gingipains from Porphyromonas gingivalis on the Human Complement
System.
The
Journal
of
Immunology,
178(11),
7242-7250.
doi:10.4049/jimmunol.178.11.7242
227. Marsh, P. D., Mcdermid, A. S., Mckee, A. S., & Baskerville, A. (1994). The
effect of growth rate and haemin on the virulence and proteolytic activity of
Porphyromonas
gingivalis
W50.
Microbiology,
140(4),
861-865.
doi:10.1099/00221287-140-4-861
228. Onozawa, S., Kikuchi, Y., Shibayama, K., Kokubu, E., Nakayama, M., Inoue,
T., . . . Hasegawa, H. (2015). Role of extracytoplasmic function sigma factors in
biofilm formation of Porphyromonas gingivalis. BMC Oral Health, 15(1), 4.
doi:10.1186/1472-6831-15-4
229. Almiron, M., Link, A. J., Furlong, D., & Kolter, R. (1992). A novel DNA-binding
protein with regulatory and protective roles in starved Escherichia coli. Genes &
Development, 6(12b), 2646-2654. doi:10.1101/gad.6.12b.2646
230. Altuvia, S., Almiron, M., Huisman, G., Kolter, R., & Storz, G. (1994). The dps
promoter is activated by OxyR during growth and by IHF and ?sin stationary phase.
Mol Microbiol, 13(2), 265-272. doi:10.1111/j.1365-2958.1994.tb00421.x

84

231. Ueshima, J., Shoji, M., Ratnayake, D. B., Abe, K., Yoshida, S., Yamamoto,
K., & Nakayama, K. (2003). Purification, Gene Cloning, Gene Expression, and
Mutants of Dps from the Obligate Anaerobe Porphyromonas gingivalis. Infection
and Immunity, 71(3), 1170-1178. doi:10.1128/iai.71.3.1170-1178.200
232. Naito, M., Hirakawa, H., Yamashita, A., Ohara, N., Shoji, M., Yukitake, H., .
. . Nakayama, K. (2008). Determination of the Genome Sequence of
Porphyromonas gingivalis Strain ATCC 33277 and Genomic Comparison with
Strain W83 Revealed Extensive Genome Rearrangements in P. gingivalis. DNA
Research, 15(4), 215-225. doi:10.1093/dnares/dsn013
233. Igboin, C. O., Griffen, A. L., & Leys, E. J. (2009). Porphyromonas gingivalis
Strain Diversity. Journal of Clinical Microbiology, 47(10), 3073-3081.
doi:10.1128/jcm.00569-09
234. Park, Y., Yilmaz, O., Jung, I., & Lamont, R. J. (2004). Identification of
Porphyromonas gingivalis Genes Specifically Expressed in Human Gingival
Epithelial Cells by Using Differential Display Reverse Transcription-PCR. Infection
and Immunity, 72(7), 3752-3758. doi:10.1128/iai.72.7.3752-3758.2004
235. Lin, X., Wu, J., & Xie, H. (2006). Porphyromonas gingivalis Minor Fimbriae
Are Required for Cell-Cell Interactions. Infection and Immunity, 74(10), 6011-6015.
doi:10.1128/iai.00797236. Daep, C. A., James, D. M., Lamont, R. J., & Demuth, D. R. (2006). Structural
Characterization of Peptide-Mediated Inhibition of Porphyromonas gingivalis
Biofilm
Formation.
Infection
and
Immunity,
74(10),
5756-5762.
doi:10.1128/iai.00813-06
237. Figurski, D. H., & Helinski, D. R. (1979). Replication of an origin-containing
derivative of plasmid RK2 dependent on a plasmid function provided in trans.
Proceedings of the National Academy of Sciences, 76(4), 1648-1652.
doi:10.1073/pnas.76.4.1648
238. Tevik Dorak, M. (2007). Real-time PCR. www.dorak.info/genetic/realtime.
html
239. Corney, D. C. (2013). RNA-seq Using Next Generation Sequencing. Materials
and Methods, 3. doi:10.13070/mm.en.3.203
240. Oshlack, A., & Wakefield, M. J. (2009). Transcript length bias in RNA-seq
data confounds systems biology. Biol Direct, 4(1), 14. doi:10.1186/1745-6150-414

85

CURRICULUM VITAE

NAME: Neelima Chowdary Cherukumalli
ADDRESS:
782 Theodore Burnett Ct # 1
Louisville, KY 40217
DATE OF BIRTH: January 22, 1990
EDUCATION & TRAINING:
Bachelor of Dental Surgery (2007-2012),
St. Joseph Dental College and Hospital,
Eluru, India
DENTAL EXPERIENCE
Associate Dentist (May’11 – Aug’12)
Sudantha Dental Clinic, Vijayawada, India
PROFESSIONAL SOCIETIES:
American Association for Dental Research (AADR) Jan 2015 – Ongoing
International Association for Dental Research (IADR) Jan 2015 – Ongoing.

86

